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«Studia prima la scienza, e poi seguita la pratica, nata da 
essa scienza. Quelli che s'innamoran di pratica senza scienza 
son come 'l nocchier ch'entra in navilio senza timone o 
bussola, che mai ha certezza dove si vada» 
 
«First study the science, then the practice born from this 
science. Those who fall in love with practice without science 
are like a sailor who enters a ship without a helm or a 
compass, and who never can be certain whither he is going» 
 
 Leonardo da Vinci 
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1. INTRODUCTION 
 
1.1 Neurotrophins 
Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), 
Neurotrophin-3 (NT-3), Neurotrophin 4 (NT-4) and Neurotrophins 6 (NT-6) 
belong to the neurotrophin family. Historically, the first family member 
identified was NGF (Levi-Montalcini et al., 1954). It was discovered during 
experiments of transplanting mouse sarcoma tissue into a chick embryo. The 
transplanted tumor tissue induced hyperinnervation of internal chick organs, by 
releasing a diffusible agent that stimulated the growth and differentiation of 
developing nerve cells. The discovery has lead, in the following years, to 
formulate the “neurotrophic hypothesis” (Purves,  1988). This theory is based on 
the assumption that the survival of neurons depends on the supply of a 
neurotrophic factor, synthesized in limiting amounts in the target fields. 
However, the neurotrophic hypothesis has been broadened by the demonstration 
that multiple neurotrophic factors regulate the survival of certain populations of 
neurons. Since the discovery of NGF, studies and findings have been continued, 
leading to exploration of the field of neurotrophins and identification of the other 
family members . Thus, in 1982 BDNF was purified from pig brain, thanks to its 
survival-promoting action on a subpopulation of dorsal root ganglion neurons 
(Barde et al., 1982). Despite the different origin and distinct neuronal specificity, 
BDNF turned out to be a close relative of NGF. Few years later, the third 
member of the neurotrophin family, NT-3, was identified (Hohn et al., 1990). 
NT-4 was isolated from Xenopus and viper (Hallböök et a1., 1991) first, and 
then, identified in both human and rat genomic DNA (Ip et al., 1992), which 
represented the mammalian counterpart of Xenopus/viper NT-4. A fifth 
neurotrophin was then cloned from the human and named NT-5 (Berkemeier et 
al., 1991; 1992). However, its chromosomal location and activity profile 
indicated that NT-5 was the ortholog of NT-4 (Berkemeier et al., 1992).  
Finally, NT-6 was only cloned from Xiphophorus maculatus, a teleost species 
(Götz et al., 1994), and is not expressed in other vertebrates. Later findings had 
suggested the existence of an additional fish neurotrophin, NT-7, cloned in the 
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carp (Lai et al., 1998) and in zebrafish (Nilsson et al., 1998). However, 
Dethleffsen and colleagues (2003) provided strong evidence that NT-6 and NT-
7, which had originally been considered different genes, have evolved from a 
single ancestral gene, which was generated by a single duplication of an 
ancestral NGF gene. 
The interest in neurotrophins has never decreased over the years: beside the 
neurotrophic factor hypothesis, which continues to guide research on the effects 
of neurotrophic factors, further studies have shed light on other mechanisms of 
neurotrophic factor action, such as anterograde transport and presynaptic release 
of neurotrophins. The neurotrophins exhibit actions on distinct, as well as 
partially overlapping, subsets of peripheral and central neurons (for a review see 
Eide et al., 1993; Ibáñez, 1995). Individual neurons may also be responsive to 
more than one neurotrophin at a given time, or at subsequent times during 
development. Moreover, the actions of neurotrophic factors are not restricted to 
developing neurons. Indeed, these factors can act on dividing neuroblasts as well 
as mature neurons that have established stable synaptic contacts. Thus,  
neurotrophins have profound influences, ranging from development, to 
differentiation, maintenance and plasticity of brain function throughout life. 
Loses in neurotrophins regulation and function place the nervous system at risk 
for cognitive malfunction and degeneration. 
  
 
1.1.1 Biochemical features 
All neurotrophins are structurally related proteins, whose genes code 
glycosylated neurotrophin precursors that are cleaved by pro-convertases to give 
rise to mature processed neurotrophins. Some features are conserved among 
neurotrophins such as 1) a presumptive signal peptide following the initiation 
codon (Leibrock et al., 1989; Ernfors et al., 1990; Hohn et al., 1990; Jones and 
Reichardt, 1990; Kaisho et al., 1990; Rosenthal et al., 1990; Maisonpierre et al., 
1990, 1991; Berkemeier et al., 1991; Hallböök et al., 1991; Ip et al., 1992); 2) a 
pro-region, including an N-linked glycosylation site, and a proteolytic cleavage 
site for furin-like proteases followed by the mature sequence (Bresnahan et al., 
1990; Seidah et al., 1996a, 1996b); 3) a distinctive three-dimensional structure 
determined by two pairs of anti-parallel b-strands, and six cysteine residues 
8 
 
forming three disulfide bridges, referred to as the cystine knot motif (McDonald 
and Hendrickson, 1993; Sun and Davies, 1995; Ibanez, 1998).  
More in details, NGF consists of three subunits, a, b and g which interact to form 
a 7S complex of approximately 27 kDa in weight. The 7S complex contains two 
identical 118 amino acid b chains, which are solely responsible for the trophic 
activity of NGF. Mature b-NGF is synthesized from prepro-b NGF and exists 
within the CNS as a homodimer. While the b-NGF monomer also exhibits 
growth promoting activity, it is the dimeric form that is the principal and 
physiological mode (Maness et al., 1994). BDNF is a basic dimeric 28-kDa 
protein of non-covalently linked 14-kDa subunits structurally related to NGF. 
Pro-BDNF, a 32-kDa precursor, undergoes cleavage to release mature 14-kDa 
BDNF protein as well as a minor truncated form of the precursor (28 kDa). 
BDNF gene consist of eight 5‟ untranslated exons and one protein coding 3‟ 
exon. Transcription of the gene results in BDNF transcripts containing one of the 
eight 5‟ exons spliced to the protein coding exon and in a transcript containing 
only 5‟ extended protein coding exon (Aid et al., 2007). NT-3 is a  polypeptide 
of 199 amino acids, and the mature rat NT-3 peptide displays a 57% amino acid 
identity with rat NGF and a 58% amino acid identity with rat BDNF. However, 
despite this structural homology, NT-3 has a distinct biological activity and a 
different spatiotemporal characteristic from both NGF and BDNF (Robinson et 
al., 1995). NT-4 precursor protein is made of 236 amino acids, it is processed 
into a 123 amino acid mature NT-4 form (Hallböök et al., 1991; Hallböök et al., 
1999). The structure of NT-6 precursor is formed of 286 aminoacids. NT-6 
contains an additional basic domain of 22 amino acid residues between cysteine 
residues 2 and 3. The corresponding region in NGF forms a loop on the protein 
surface (Götz et al., 1994). This domain might be responsible for the observed 
interaction of NT-6 with the glycosaminoglycan heparin that affects the release 
of NT-6 from the extracellular matrix and cell surface (Götz et al., 1994). The 
mature part of all neurotrophins shows a high degree of sequence similarity, and 
approximately 50% of the amino acids are common to all neurotrophins. The 
mature proteins often build noncovalently linked homodimers as active forms 
(for review see Bibel and Barde, 2000).  
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1.1.2 Neurotrophins and receptors  
The signal transduction systems, that mediate the diverse biological functions of 
the neurotrophins, are initiated through interactions with two categories of cell 
surface receptors, the p75 neurotrophin receptor and the tropomyosin-related 
kinase (Trk) tyrosine kinase receptors (for a review see Schecterson and 
Bothwell, 2010). p75 was the first receptor to be discovered and was identified 
as a low-affinity receptor for NGF, but was subsequently shown to bind each of 
the neurotrophins with a similar affinity (Rodriguez-Tebar et al., 1991; Frade 
and Barde, 1998). p75 is a member of the tumour necrosis receptor superfamily 
with an extracellular domain that includes four cysteine-rich motifs, a single 
transmembrane domain and a cytoplasmic domain that includes a „death‟ 
domain similar to those present in other members of this family (Liepinsh et 
al.,1997; He and Garcia, 2004). p75 binds to all members of the neurotrophin 
family, and even the proneurotrophins, along the interface between the two 
monomers and triggers a number of pathways depending on the cellular context. 
Among these, some pathways may indirectly end up in cell cycle regulation, 
such as activation of ceramide (Cer), c-Jun N-terminal kinase (JNK), Rac, NF-
kB, and Ras. The other group of neurotrophins receptors is made of the 
subfamily of receptor tyrosine kinases (Trk) (Mitra et al., 1987; Martin-Zanca et 
al., 1989). Three distinct genes encoding Tks have been studied in vertebrates: 
TrkA, TrkB and TrkC (for a review see Huang and Reichardt, 2003). These are 
transmembrane receptors, with an extracellular domain which consists of a 
cysteine-rich cluster followed by three leucine-rich repeats and a cytoplasmic 
tyrosine kinase domain. Each receptor spans the membrane once and is 
terminated with a cytoplasmic domain consisting of a tyrosine kinase domain 
surrounded by several tyrosines that serve as phosphorylation- dependent 
docking sites for cytoplasmic adaptors and enzymes (Reichardt, 2006). Thus, the 
main mechanism of action, when Trks bind to neurotrophins, is the activation 
through transphosphorylation of the kinases present in their cytoplasmic 
domains. A number of intracellular signaling cascades including, among others, 
the ras/extracellular regulated kinase (erk) and the phosphatidylinositol-3 kinase 
(PI 3 kinase) cascades, which result in regulating the differentiation and survival 
of neurons, are activated. The binding to the receptors Trks or p75 is related to 
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different degree of affinity, depending also on different binding sites. Affinity to 
the specific neurotrophin determines both the responsiveness and specificity of 
neurotrophin itself. Trk receptors show high binding affinity: NGF and NT-6 
binds preferentially to TrkA; BDNF and NT-4 to TrkB; and NT-3 to TrkC. 
Further studies have highlighted that the binding of NGF to TrkA, and BDNF to 
TrkB is of low affinity but it can be regulated by receptor dimerization, 
structural modifications or association with the p75 receptor (Arevalo et al., 
2000; Esposito et al., 2001). The p75 receptor can bind to each neurotrophin, 
and also acts as co-receptor for Trk receptors  as shown in Fig 1. Expression of 
p75 can increase the affinity of TrkA for NGF and can enhance its specificity for 
cognate neurotrophins (Hempstead et al., 1991; Benedetti et al., 1993; Bibel et 
al., 1999). As a result, increased ligand selectivity can be conferred on the Trk 
receptors by the p75 receptor. In addition to forming complexes, Trk and p75 
receptors show independent signalling properties, and downstream signal 
transduction pathways significantly contribute to individual physiological 
responses.  
 
 
Fig 1. Neurotrophins bind selectively to specific Trk receptors, whereas all neurotrophins bind to 
p75. Neurotrophin binding to the p75 receptor mediates survival, cell migration and myelination 
through several signalling pathways. Interactions between Trk and p75 receptors can lead to 
changes in the binding affinity for neurotrophins. Abbreviations: JNK, Jun N-terminal kinase; 
MAPK, mitogen-activated protein kinase; NT, neurotrophin; PI3K, phosphatidylinositol 3-
kinase; PLC-γ, phospholipase Cγ. (Chao, 2003) 
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The biological effects of neurotrophins require that signals be conveyed over 
long distances. After neurotrophin-mediated activation, the receptors shuttle 
back from the axon terminals to the soma by retrograde transport in so-called 
signaling endosomes to regulate gene expression and exert their trophic 
responses. Endosomes are delivered to the cell body where signals are 
transduced to ensure neuronal survival and differentiation. Endosomes serve as a 
meeting point for the formation of signaling complexes for a wide variety of 
ligands and their receptors. Since the formation of transport vesicles would 
orient the intracellular domain of the receptors to face the cytoplasm, each 
receptor would be available for interactions with cytoplasmic proteins and 
produce many signaling possibilities (for a review see Chao, 2003). The 
retrograde trafficking process is well studied, and is becoming increasingly clear 
(Hirokawa et al., 2009). Conversely, assumed mechanisms underlying 
anterograde Trk transport remain incompletely understood. Possible 
explanations on anterograde axonal transport involves heatshock proteins, such 
as HSP90, which bind to TrkB during axonal transport (Bernstein et al., 2001), 
and APP, which may be a kinesin endosome receptor for a subset of transport 
vesicles (Kamal et al., 2000). Because multiple kinesin isoforms are expressed 
in neurons, it could be hypothesized that different kinesins may be responsible 
for anterograde axonal transport of different types of endosomes, possibly 
facilitating their targeting to different destinations or uses, but as of yet, there is 
little direct evidence for this mechanism. However, recent evidences have 
indicated the involvement of sortilin as an important anterograde trafficking 
receptor for the Trk proteins (Vaegter et al., 2010). 
 
1.1.3 Biological activities 
The neurotrophin proteins are crucially involved in regulating the survival and 
differentiation of neuronal populations during development (Levi-Montalcini, 
1987; Davies, 1994; Lewin and Barde, 1996; Chao, 2003). In addition to these 
well-established functions in development, a large body of work suggests that 
neurotrophins continue to shape neuronal structure and function throughout life 
(Schnell et al., 1994; Thoenen, 1995; Bonhoeffer, 1996; Prakash et al., 1996). 
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For example, NGF has been shown to influence neuronal soma size, dendritic 
complexity (Ruit et a1., 1990), and the number and size of synaptic contacts in 
the brain (Garofalo et al., 1992). Other neurotrophins may have similar effects 
on different central nervous system populations, and long-term morphological 
changes are of obvious importance in functional connectivity (Lisman and 
Harris, 1993; Pierce and Lewin, 1994). Neurotrophins such as BDNF and NT-3 
produce rapid increases in synaptic strength in nerve–muscle synapses, as well 
as increases in excitatory postsynaptic currents in hippocampal neurons (Jacobi 
et al., 2010). BDNF and NT-3 also induce rapid and long-lasting enhancement 
of synaptic strength through LTP in hippocampal cells cultures. 
Additionally, neurotrophins represent strong candidates in regulating the 
continued plasticity of multiple brain systems long beyond the early organization 
that occurs during embryonic and perinatal period and adulthood. This is 
particularly true for BDNF, a key molecule critical in the control of 
neurogenesis, since it impacts cell proliferation within the neurogenic zone of 
mammalian brain (Bath and Lee, 2010), and contributes to the process of 
neuroblast migration (for a review see Bath and Lee, 2010). Well established is 
also the role of neurotrophins in the regeneration processes. In fact, it has been 
noted that neurotrophin secretion increases in the nervous system following 
injury. BDNF and NGF secretion increases dramatically within hippocampal 
neurons depolarized by kainic acid (Zafra et al., 1990) or following ischemic 
injury (Lindvall et al., 1992). Although Schwann cells, fibroblasts, and activated 
mast cells normally synthesize NGF constitutively, direct trauma and induced 
cytokines combine to increase neurotrophin production in these cells after injury 
(for a review see Levi-Montalcini et al., 1996). Among  all neurotrophins, the 
actions of BDNF on central neurons have been best characterized. Indeed, 
modest changes in BDNF levels or expression of altered single nucleotide 
polymorphism in the BDNF gene is correlated with neuroanatomical differences 
and behavioral changes in humans and in mouse models, including abnormal 
feeding behavior, alterations in episodic memory, and susceptibility to 
neuropsychiatric disorders of anxiety and depression (Lyons et al., 1999; Egan et 
al., 2003; Chen et al., 2006; Castren and Rantamaki, 2010; Russo et al., 2009). 
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However, changing in the regulation and function of all members of 
neurotrophin family place the nervous system at risk for cognitive malfunction 
and degeneration. In the brain aging and in neurodegenerative disorders, there is 
a fragile balance between neurotrophic factor support and dysfunction. Many 
evidences highlight the strong implication of neurotorphic factors and 
neurotrophins in particular in CNS disfunction (for a review see Connor and 
Dragunow, 1998). It is unclear whether alterations in neurotrophins and their 
receptors expression are primary or secondary to the neuropathological changes 
associated with each disorder. Indeed, while it has not been determined whether 
those alterations precede the development of the disease process, it is possible 
that the observed alterations in neurotrophins or receptors may be involved in 
the primary pathogenesis of specific neurodegenerative disorders (for a review 
see Connor and  Dragunow, 1998). Based on these observations, members of the 
neurotrophins family could have potential therapeutic roles in preventing and, or 
reducing the neuronal cell loss and atrophy that occurs in neuronal aging and in 
neurodegenerative disorders such as Alzheimer diseases, Parkinson‟s disease, 
Huntington‟s disease or amyotrophic lateral sclerosis (ALS).  
 
1.1.4 Neurotrophins as Therapeutic Agents 
The involvement of neurotrophins in biological processes linked to the 
emergence of severe and widespread pathologies has suggested their use as 
promising therapeutic agents. Several investigations have provided support for 
this idea (Covaceuszach et al., 2009), however, the use of neurotrophins as drugs 
has been hampered by their poor pharmaceutical properties (Stanzione et al., 
2010). Clinical trials using neurotrophins molecules have been performed in 
some neurodegenerative diseases, such as Alzheimer disease, Parkinson disease, 
Hungtinton disease, ALS (for a review see Hefti, 1997).  
Basically, two approaches are currently studied. First, the development of 
mimetics endowed with neurotrophin-like activities: neurotrophin proteins could 
be replaced by active peptide fragments or molecules that mimic the active sites 
of neurotrophic factors. Second, the specific manipulation at any step in the 
synthesis, release, and transduction mechanism of endogenous growth factors. 
The neuroprotective effects of BDNF in rodent and primate of Alzheimer‟s 
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disease demonstrated efficacy of intraventricular infusions of growth factors and 
intraparenchymal infusions or gene delivery (Nagahara et al., 2009). The broad 
neuroprotective effects of entorhinal BDNF administration in several animal 
models of Alzheimer‟s disease, with extension of therapeutic benefits into the 
degenerating hippocampus of rodents and primates, provides a rationale for 
exploring clinical translation (Nagahara et al., 2009). 
 
1.1.5 Phylogenesis of neurotrophins 
Neurotrophins and Trk receptors represent good examples of molecules driving 
experience-dependent changes involving neuronal selection, survival and 
plasticity within the nervous system. Thus, genes that drive such experience-
dependent changes are subject to selection. Indeed, genes encoding 
neurotrophins molecules have undergone molecular changes during evolution.  
All neurotrophins contain a highly conserved C-terminal domain and bind to the 
same receptor family. Both correct folding and post-translational processing of 
the entire pre-proprotein are necessary for sorting to the extracellular space, 
dimerization and receptor binding. Studies of molecular evolution have 
highlighted that neurotrophins are highly conserved in vertebrates evolution. 
Neurotrophins and their cognate Trk receptors have been found in vertebrates 
including reptiles, amphibians, fish, birds and mammals (for a review see 
Hallböök et al., 2006), while NT-4 has not been found in chicken, the only bird 
species whose complete genome is currently available (Hallböök et al., 1991), 
and NT-6 has been isolated only in fish (Götz et al., 1994). A phylogenetic 
analysis of the neurotrophin and Trk gene families has been performed either on 
mature aminoacid sequences and on nucleotide sequences of selected organisms 
at different evolutionary stages (Hallböök et al., 1991; van Kesteren et al., 1998; 
Hallböök et al., 1999; Lanave et al., 2007). The analysis supports the notion that 
neurotrophins evolved early in vertebrate history during the two rounds of 
genome duplication that characterized the origin and evolution of vertebrates 
(Hallböök et al., 2006). This evidence has been further confirmed in the detailed 
analysis of the study on BDNF phylogenesis in vertebrates (Tettamanti et al., 
2010), where the coding sequence for the BDNF protein in 36 different 
vertebrates, ranging from mammals to fish, was investigated  to evaluate 
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whether the evolutionary selection played a major role in the evolution of the 
neurotrophins (Tettamanti et al., 2010). BDNF cDNA underwent some degree of 
selective pressure in molecular evolution through the vertebrate phylogenesis, 
clustering together species belonging to the same class. An adaptive type of 
selective pressure seemed to be responsible for clustering of mammals apart 
from other classes. The mutants arose from point mutations as well as 
insertion/deletions modalities: these last are especially represented in teleosts. 
Differently conserved regions are recognized along the sequences, 
corresponding to different parts of the transcript. In fish, the knowledge of 
neurotrophins is rather limited. Only recently, several researches, supported by 
phylogenetic analysis, have turned the attention on the biological role of 
neurotrophins by using  fish as alternative model to rodents. Significant 
advances have been made in the field of neurobiology of fish and neurotrophins 
occupy a rather large space.  
 
1.1.6 Neurotrophins in fish  
In fish, synthesis and activity of neurotrophins have been studied (for a review 
see  Heinrich and Lum, 2000), and investigations have been mainly devoted to 
characterize the molecular aspects of neurotrophins. In fish, as in mammals, 
neurotrophins are synthesized as precursors, and then they are cleaved to get the 
mature form.  
Information on the primary structure of all fish neurotrophins have been 
gathered from cloned cDNAs or genes, following cloning and nucleotide 
sequencing (Heinrich and Lum, 2000). The overall organization of all 
neurotrophin genes is similar: there is one major exon, enconding the whole 
precursor. Slight differences can be noticed among all neurotrophins.  BDNF-
encoding exon possesses four upstream exons and a separate promoter. The 
mature BDNF transcripts possess two exons: the first is one of the four upstream 
exons and the second is the BDNF-encoding major exon (Hashimoto and 
Heinrich, 1997). NT-3 gene has a similar organization, characterized by two 
upstream exons possessing a separate promoter (Leingartner and Lindholm, 
1994). 
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NGF transcripts contain up to four exons encoding a NGF precursor that is 
extended at the N-terminus. The upstream organization of the NT-4 gene is 
similar to that of the NT-3 gene. There are two promoters, each generating a 
different 5' end of the NT-3 transcripts. All transcripts therefore contain two 
exons. The second exon encodes the NT-4 precursor (Heinrich and Lum, 2000). 
The organization of the NT-6 presents 4 exons (Dethleffsen et al., 2003). With 
regards to the structures of proteins, fish neurotrophins have the same three-
dimensional structure as the mammalian ones. Studies based on crystallography 
and mutagenesis have revealed that the amino acid residues have three-
dimensional structure (Götz et al., 1994). Moreover, like in mammals,  
neurotrophins are able to form dimers, since they activate the 
autophosphorylation of Trk receptors and to do that, they require dimers (Woo et 
al., 1998).  
Neurotrophin genes are expressed in fish at the RNA level (Ip et al., 1992; 
Hashimoto and Heinrich, 1997), both in development and adulthood.  
The functional roles of neurotrophins in fish is still matter of debate. So far, 
hypothesis have been formulated. Actions may correlated to regulation of 
programmed neuron death and survival during the development and in the 
adulthood (Eisen et al., 1990; Pike et al., 1992). Furthermore, neurotrophins can 
be deeply involved in the regeneration and neurogenic activities of fish. Teleost 
fish possess the considerable capacity to generate new neurons in the adult CNS, 
the so-called “adult neurogenesis”, and to regenerate whole neurons after injury, 
the “neuronal regeneration”, in contrast to limited plasticity of the adult 
mammalian CNS (Zupanc and Sîrbulescu, 2011). Neurotrophins, and 
particularly BDNF, may represent a strong candidate in regulating the continued 
plasticity of multiple brain systems long beyond the early organization that 
occurs during embryonic and perinatal period (Bath et al., 2011). 
 
 
 
 
 
17 
 
 
1.2 Nothobranchius furzeri 
 
Fig 2. N. furzeri. Strain MZM8 (long-lived phenotype). Adult male. 
 
1.2.1 Nothobranchius furzeri 
Nothobranchius furzeri is a Teleost fish, member of the superorder 
Atherinomorpha, of the order Cyprinodontiformes.  
The name Nothobranchius is due to a peculiarity:  the presence of a fake gill 
opening in the operculum, furzeri originates from the name of the collector 
Furzer, who collected eggs in South-Eastern Africa over 40 years ago. Indeed, 
Nothobranchius furzeri is an African Annual fish, which origins mainly from 
Mozambique and Zimbabwe. This Annual fish inhabit ephemeral pools 
(typically on flood plains) in Eastern Africa and have adapted to the routine 
drying of their environment by evolving desiccation resistant eggs that can 
remain dormant in the mud for one and maybe more years (Genade et al., 2005). 
The life expectancy in the wilderness cannot exceed the seasonal duration of the 
habitat, which is in the order of months. In captivity, the life span is likewise 
short even in constant presence of water.  
To date, different strains of N. furzeri have been collected and are distinguished 
by the collection places. The strain originating from Mozambique is 
characterized by long-lived phenotype (median life-span is up to 12 months) 
while the strain from Zimbabwe comprises extremely short-lived phenotype 
(median life-span is of just three months) (Terzibasi et al., 2007).   
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These animals are extremely sexually dimorphic and dichromatic; males are 
robust and colourful, and females are smaller and pale yellow or brown. Females 
of related species can hardly be distinguished morphologically and the 
classification is based mainly on male livery and size. They are relatively small 
fishes with a median size of 5 cm (ranging from 3 to 15 cm). These fishes are all 
adapted to survive in temporary waters and all produce eggs which not only 
resist desiccation but require a dry period to develop correctly, at least in 
captivity. They all express a stereotyped behavioural pattern in which the male 
drives the female toward the substrate, in order to lay eggs in the muddy bottom. 
 
1.2.2 Phylogeny 
The order Cyprinodontiformes comprises Fundulus heteroclitus (the so-called 
mumi-chog), Poecilia reticulata (the popular aquarium fish guppy) and 
Xiphophorus (the platyfish).  
Molecular phylogenetic analyses, based on whole mitogenome sequences 
(Setiamarga et al., 2008), have provided evidence that the order 
Cyprinodontiformes is a sister group of  Beloniformes, whose main representant 
is Orizyas latipes, well known as medaka.  
All these species are widely employed in biomedical research for studies of 
ecology, evolution and genomic resources. Therefore, taking into account the 
phylogenetic analyses, Nothobranchius occupies a  very convenient position for 
performing comparative genomics and molecular studies. 
The genus Nothobranchius includes about 50 currently described species, 
separated into 5 well-defined clades (Huber, 2005; Wildekamp, 2004) and a 
series of other taxa. The different species present a biodiversity, accoding to the 
variations of regions where they come from. 
Remarkable variations in regional climate and precipitation patterns are 
observed in Nothobranchius habitats. Some (e.g. Zanzibar) have two short dry 
seasons which punctuate the long wet season (Wildekamp 2004), while other 
localities may not dry out at all in some years (e.g. Mafia Island) (Seegers, 
1997). By contrast, some of the locations where Nothobranchius is found, such 
as Sudan or the Kruger National Park, show brief and erratic rainy seasons and 
may not receive sufficient rain for several years (Jubb, 1981). 
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Differences in precipitation patterns result in large-scale differences in captive 
longevity not only for different Nothobranchius species, but also for different 
populations of the same species.   
 
1.2.3 Distribution, polymorphism and habitat 
Data on the distribution, ecology and demography of N. furzeri are essential for 
their full appreciation in studies investigating the evolutionary origin and 
consequences of ageing (Genade et al., 2005). The distribution range is between 
Southern Mozambique and Gona Re Zhou Game Reserve in Zimbabwe. More 
precisely, the distribution range comprises three broadly-defined watersheds. 
The first is the set of temporary rivers that flow from the plateau of Gona Re 
Zhou (about 400m) in Zimbabwe into Mozambique. This watershed is referred 
to as the "Chefu" basin. The second watershed is the Limpopo. The third 
watershed is defined by the rivers Vaneteze and Mazimechopes and draws into 
the Incomati. The river Save represents the western limit of the distribution 
range for N. furzeri.  
According to different distribution, two colour morphs are expressed in male of 
N. furzeri. In the type population in the upper Chefu basin, only yellow males 
were found (Jubbs, 1972). In the lower Chefu basin, all populations were 
composed of a mixture of yellow and red males, while only 7 out of 13 
populations in the Limpopo basin contained any yellow males. The yellow 
morph also dominated in the Incomati basin in the south-western part of the N. 
furzeri range, with exclusively yellow males found in the Vaneteze basin and 
yellow-dominated populations in the Mazimechopes basin. In contrast, the red 
morph dominated in most populations in the Limpopo basin that includes the 
centre and the largest part of the N. furzeri range (Reichard et al., 2009). 
The habitat of Nothobranchius is characterized by vertisol soils on alluvial 
deposits (Wildekamp, 2004), because vertisols provide suitable soil structure for 
survival of dormant eggs during the dry season (Wildekamp, 2004). N. furzeri 
often inhabited simple shallow pools without any vegetation. Within pools with 
vegetation, N. furzeri typically occurred in Nymphaea in close proximity to open 
water or at the interface between vegetation and open water.  
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1.2.4 Life cycle  
N. furzeri  is an Annual fish. As the name suggests,  the life cycle is completed 
within a year: the eggs require a dry period to develop fully. As previously 
described, these fish inhabit areas that are subject to seasonal rainfall - creating 
bodies of water. As the year progresses, the water levels drop, and after several 
months dry up completely. They bury their eggs in the substrate, and die when 
the pool evapourates. A few months later, the rains come again, bringing life to 
the pool, and allowing the now fully developed embryos to hatch. The weather is 
always unpredictable, so the fry must grow quickly, reach maturity and 
reproduce before the pool dries up again. In general they are fast growers, 
reaching adulthood after a few weeks. Sometimes, the fish do not reach the adult 
stage, however, this does not spell the end for the population. The eggs go 
through several distinct stages in their growth, including resting periods called 
diapauses.  
Under laboratory conditions, diapause is characterized by three stages (Wourms 
1972a; Wourms 1972b; Wourms 1972c). In DI (the first diapause) blastogenesis 
has completed and embryogenesis has not yet begun. At DII embryogenesis is 
complete and organogenesis has not begun. At DIII organogenesis is complete 
and the fully formed fry awaits the environmental cue to hatch.  
 
 1.2.5 Nothobranchius furzeri as model organism 
In biomedical and veterinary research, vertebrate and invertebrate model 
organisms are widely employed: they present great advantages for identifying 
and understanding genes that are altered in heritable human diseases. The 
functions of many of those genes, have remained largely intact in both 
vertebrate and invertebrate lineages during the ensuing course of evolution. 
Among vertebrates, fish occupy a special position: their organ systems, 
including the brain, the heart, the hematopoietic system, and the digestive and 
excretory organs, are similar to those of other vertebrates. Fish are useful 
model for ageing research: their short lifespans, the relatively low cost of 
maintaining large numbers of individuals for lifetime studies, and in many 
cases, a well-developed genetics. Particularly, N. furzeri has been proposed as 
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a new model system for aging research (Genade et al., 2005; Terzibasi et al., 
2007): it is the shortest-lived vertebrate which can be cultured in captivity 
(Valdesalici and Cellerino, 2003). N. furzeri can be cultured, and their eggs 
stored dry at room temperature for months or years, offering inexpensive 
methods of embryo storage; they show accelerated growth and expression of 
aging biomarkers at the level of histology and behaviour; the so-short lifespan 
offers the possibility to perform investigations thus far unthinkable in a 
vertebrate, such as drug screening with life-long pharmacological treatments 
and experimental evolution; when the lifespan of different species is compared, 
a general correlation is found between wet season duration in their natural 
habitat and longevity in captivity; and vertebrate aging-related genes, such as 
p66Shc and MTP can be easily isolated in Nothobranchius by homology 
cloning.  
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
1.3 Scientific significance of teleost fish for 
neurobiological research 
 
The brain of Teleosts has gained considerable importance in the neuroscience 
field: the use of “neurobiological models”, that are “simpler” than the 
mammalian brain, might facilitate research into central nervous system (CNS). 
Studies in the basic neurosciences have been focused predominantly upon rat 
and mouse models. The majority of studies conducted are performed on either 
rats or mice, with humans as a close second. A confirmation of this status 
comes from an analysis of Manger and coworkers (2008), who analysed 
publications in the basic neurosciences (to the exclusion of the clinical 
neurosciences) from 12 general neuroscience journals covering a variety of 
specializations for the years 2000–2004, plus two journals that specifically 
target the comparative neuroscience community (Brain, Behavior and 
Evolution and The Journal of Comparative Neurology) over the period 1975–
2004. What they assessed was that studies on species other than rodents are 
more limited, and the proportion of journal space dedicated to the various 
species that form the objects of scientific study is rather low.  
However, the complete genomes of many species, the accelerating pace of 
bioinformatics as a directive research tool, and the technical advances being 
made especially in molecular and developmental neuroscience support and 
reinforce the study of species with phenotypes different to rats and mice, such 
as fish. Comparative neurobiology can provide insight about the human 
nervous system and its role in health and pathological conditions. Fish models 
can lead to understanding of vertebrate neurology in general, and provide 
perspective by their fundamental evolutionary relationship with other 
vertebrates. Certain progressive neurological diseases are best understood in 
the context of the evolutionary states of the nervous system in which 
evolutionarily "higher" CNS functions are lost first, then sequentially "lower" 
evolutionary states, with the order being reversed during recovery. 
The main architecture of the fish brain resembles that of the mammals, despite 
differences mainly in the development of the telencephalon. Although they 
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cannot replace clinical research, there is much to be learnt from fish brains. 
The knowledge of the brain architecture of fish is necessary to study the neural 
basis of behavior and mechanisms relevant for neurological processes and 
neurodegenerative diseases. 
In fish, as in other vertebrates, two prominent external constrictions divide the 
early developing brain (neural tube) into the three neural vesicles giving rise to 
the basic regions of the adult brain: forebrain (or prosencephalon), midbrain 
(or mesencephalon), and hindbrain (or rhombencephalon). These vesicles 
represent the fundamental antero-posterior (i.e., rostrocaudal) subdivisions that 
later on may become subdivided into more or less evident transverse bands or 
neuromeres, which have defined relations with other structures of the head and 
the peripheral nervous system, being very useful in comparative studies. 
Because the developmental genes that are involved in mammalian brain 
development are largely conserved, comparisons between fish and mammalian 
brain development can be made through the analysis of gene expression.  
The analysis of gene and the anatomical studies combined with the use of 
molecular techniques could lead to significant advances in the understanding of 
human neural disorders as well as human brain evolution. 
 
1.3.1 The central nervous system of teleosts  
The teleost brain is composed of three major regions: the forebrain, midbrain, 
and rhombencephalon. The forebrain can be further subdivided into the 
telencephalon and diencephalon. The midbrain is subdivided into a dorsal part, 
entirely occupied by lobes of optic tectum, and the ventrally located 
tegmentum. The rhombencephalon encompasses cerebellum and medulla 
oblongata, respectively dorsal and ventral positioned, and does possess 
structures that are present in the mammalian pontine tegmentum (the tegmental 
region dorsal to the pons sensu stricto). The above-mentioned structures can be 
identified in teleosts as well, e.g. the locus coeruleus and the principal 
trigeminal nucleus, and this region may be called the “pontine area.” In 
teleosts, the latter area includes the lateral nucleus of valvula which receives 
telencephalic inputs and projects fibers to the cerebellum. The nucleus may 
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share a similar ontogenetic origin to the mammalian pontine nuclei, suggesting 
their homology (Yang et al., 2004).  
 
Telencephalon  
The telencephalon represents the most rostral part of encephalon. It consists 
mainly of olphactory bulbs and telencephalon sensu strictu or telencephalic 
hemispheres. The olphactory bulbs are sessile and organized in layers, whose 
boundaries are not very distinct. From the most external layer, it can be 
recognized: an outer layer of primary olphactory afferent fibers, a glomerular 
layer, a layer of mitral cells or external cellular layer and an inner layer of 
granule cells.  The olphactory bulbs receive a so-called primary olphactory 
input from sensory nerve cells in the sensory epithelium of the olphactory 
organ. The pathway is via the olphactory nerve. Both the bulbs are 
interconnected via the medial oplhactory tract and project predominantly to the 
ventral area of telencephalon and dorso-posterior telencephalon. The 
telencephalon is subdivided into a dorsal and ventral area, each with a number 
of cytoarchitectonically delineable subdivisions. In the dorsal area, it is 
possible to recognize dorso-lateral, dorso-dorsal, dorso-medial and dorso-
central areas. Dorso-lateral and dorso-medial areas present a high density of 
small neurons, mainly organized in layers, whereas the dorso-central area 
consists of larger neurons. The dorso-posterior telencephalon is an important 
source of olphactory bulbs afferents and consists mainly of fibers. The ventral 
area is divided into a ventro-dorsal, ventro-ventral, ventro-lateral areas,  
supracommissural and post-commissural parts. All these subdivisions are 
mainly characterized by small neurons and neuronal processes projecting back 
to olphactory bulbs or to midbrain regions. 
 
Diencephalon  
The diencephalon is located between the telencephalon and mesencephalon:  
the rostral boundary is the preoptic area and the caudal boundary is the 
pretectal region. The diencephalon is subdivided into epithalamus, thalamus, 
and hypothalamus zone. The preoptic area is regarded as the most rostral 
diencephalic subdivision, and includes the preoptic and suprachiasmatic nuclei. 
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By cytomorphological criteria, the preoptic nucleus is split into a 
magnocellular and parvocellular portions, respectively located dorsally and 
superiorly, in the periventricular zone. The epithalamus represents the 
rostrodorsal part of diencephalon and comprises the habenular nuclei, the 
epiphysis and the dorsal saccus. Habenular nuclei and epiphysis are 
interconnected structures, since input arise from one and reach the other. 
Moreover, epiphysis plays a key role in the synchronization of activity rythms 
with the dark-light cycle. The thalamic “complex” includes a dorsal and ventral 
thalamus. This complex is the major sensory relay station of the brain, 
receiving all inputs (except olfaction) and connecting reciprocally with the 
overlying structures. Particularly, thalamic nuclei are characterized as a 
multimodal relay centre, relaying visual, somatosensory, acoustico-lateral and 
cerebellar input to the telencephalon. The dorsal thalamus of teleosts does not 
appear to serve as the major sensory relay center to the telencephalon 
(Northcutt, 2006); whereas accumulating evidences suggest that the 
preglomerular complex, located ventrolateral in the thalamus, serves as the 
major sensory relay station to the telencephalon (Northcutt, 2006).  The 
hypothalamus, as the name implies, is located below the thalamus and 
represents the ventralmost diencephalic region. It is connected with the 
hypophysis by means the pituitary stalk, which contains hypothalamic and 
preoptic nerve fibers involved in neuroendocrine regulatory functions. In the 
teleostean hypothalamus, a periventricular zone and inferior lobe can be 
recognized.  Finally, the pretectal region is located in front of the rostral 
margin of the optic tectum and  includes both diencephalic and mesencephalic 
structures. Functionally, the pretectum may be characterized as a primarily 
visual region, receiving both retinal and tectal visual input. 
 
Mesencephalon 
The mesencephalon or midbrain consists of a dorsally located tectum, named 
optic tectum, a ventromedially located tegmentum and a ventrolaterally located 
semicircular tori. This general subdivision reflects a diverse functional role of 
the structures. Indeed, the optic tectum is mainly involved in sensory functions, 
whereas the ventromedial and ventrolateral structures have predominantly 
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involved in (pre)motor functions. The optic tectum is a paired structure, 
organized in layers. Anteriorly, at the medial tectal margin there is a paired 
structure, named longitudinal tori, one of the main source of visual projection 
to optic tectum. The optic tectum is not only involved in visual inputs 
processing, but also in integration of visual signals with sensory information, 
and in generation and coordination of goal directed movements. Thus, it is 
considered as one of the main sensorimotor integration centers of the 
teleostean CNS. The tegmentum encompasses many motor structures, such as 
the oculomotor and trochlear nuclei, and continues into the medulla oblongata 
without any sharpen boundary.  
 
Rhombencephalon 
The rhombencephalon is the most caudal part of the brain. Caudally it 
continues gradually in the spinal cord. It is composed of the dorsoanterior 
cerebellum, the ventroanterior pons and posterior ventrally located medulla 
oblongata. The cerebellum basically consists of three main regions: the 
valvula, the part protruding rostrally into the mesencephalic ventricle, the 
corpus, centrally located, and the caudal cerebellar region which consists of the 
caudal lobe and granular eminentiae. The primary role of the cerebellum is to 
coordinate movement, and it thus receives information from many sources 
while transmitting information primarily to motor cortical areas.  
The medulla forms the fourth ventricle of the brain, and together with the 
midbrain, are often referred to as the “brainstem”. The brainstem contains a 
conglomerate of cell groups that form a complex network termed the reticular 
formation, which is involved in higher order behaviors such as respiration, 
circulation, and wakefulness. The hindbrain also contributes 8 of the 10 pairs 
of cranial nerves, numbers V through X. Cranial nerves can have both motor 
and sensory components, and those derived from the hindbrain are responsible 
for a wide variety of behaviors, including taste, hearing, balance, mastication, 
facial expressions, some eye movements, and, in terrestrial vertebrates, the 
secretion of tears and saliva. 
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2. AIMS 
In biomedical and veterinary research, growing interests have been shifted to 
study alternative model organisms, which could replace the traditional ones. The 
sought model should be easy to manipulate and manage, economically 
advantageous, simple for anatomical and physiological organization. Particularly 
in aging and in neurobiology research, to explore the root causes of aging 
processes of brain, fish are useful models, because most of their organ systems, 
including the brain, the heart, the hematopoietic system, the digestive and 
excretory organs, are similar to those of other vertebrates.  
The main core of the thesis is a neuroanatomical study of the CNS of the teleost 
model N. furzeri, whose biological features make it suitable for aging research 
(Terzibasi et al., 2007).  
The first step of the research project was the neuroanatomical study of the brain 
of N. furzeri. Atlases of other teleostean species are available, however given the 
high interspecies variability existing in fish, the neuroanatomical differences 
raised the need to realize a specific atlas of the CNS of N. furzeri. Therefore, the 
main structures and neural circuits of central nervous system of this teleost were 
identified and characterized and the schematic drawings are reported.  
Then, the research has continued aiming at investigating the presence and 
localization of neurotrophins, specifically BDNF, NGF, NT-3, NT-4 and NT-6, 
in the adult CNS of the teleost N. furzeri. Neurotrophins are members of the 
growth factor family, which play crucial roles in both the developing and mature 
mammalian nervous system. They are important during development in 
regulating neuronal survival, promoting axonal pathfinding and elongation 
towards targets, and in supporting synaptic plasticity (Gillespie, 2003; Cohen- 
Cory and Lom, 2004), and are involved in neuronal plasticity and survival in the 
adult nervous system. Thus, physiologic or pathologic age-associated changes in 
the CNS might be attributable also to an impairment of regulation of 
neurotrophins in brain.  
Previous studies in lower vertebrates have shed light on the role of neurotrophins 
during developmental stages or regenerative processes after trauma or injury of 
nervous system (Dalton et al., 2009; Germanà et al., 2010a,b; Laramore et al., 
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2011), but no extensive studies have been performed on the whole brain of an 
adult teleost. Moreover, fish possess the ability to generate new neurons at all 
stages of life. This ability may involve novel functions of and responses to 
neurotrophins and likely mimes this ``natural act'' in the human brain. In order to 
gain insight, ISH was carried out on brain sections by testing a “classical” and a 
new type of probe. The expression gene pattern has been completed by the study 
of distribution of each neurotrophin protein, by employing 
immunohistochemistry technique. The detailed mapping of neurotrophins 
expression and distribution throughout the CNS of N. furzeri may help to 
characterize the functional mechanisms into different regions of the teleost brain.    
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3. MATERIALS AND METHODS 
        
3.1 Animals 
For this study, wild-type N. furzeri from the strain WZZM 07/10 were 
employed. 40 adult fish were housed in 40L tanks at 25°C, with an “air 
supplied” water filtration and low water flow. Food was supplied twice a day, 
and consisted of commercially available, frozen bloodworm larvae (Chironomus 
sp.). Fish were maintained in 12 hours light/dark cycles. Adult subjects were let 
spawning on a river sand substrate, which was weekly sieved and returned to the 
bottom of the tanks. For the experimental procedures, all animals were 
anesthetized with 0.1% ethyl 3-aminobenzoate, methanesulfonate (MS-222; 
Sigma-Aldrich Chemical Co., St. Louis, MO). 
 
3.2 Solutions 
Solutions were prepared with bidistillate water. Solutions were autoclaved for 20 
min at 121 bar or filter sterilized (0.2-0.45 μm pore diameter). Glassware was 
autoclaved. For RNA-work, solutions and water were treated with 0.1% 
diethylpyrocarbonate (DEPC), shaked vigorously and mixed for about 20 min on 
a magnetic stirrer to bring the DEPC into solution. The solutions were then 
autoclaved to remove any trace of DEPC. Tris buffers cannot be treated with 
DEPC because it reacts with primary amines. DEPC decomposes rapidly into 
CO2 and ethanol in the presence of Tris buffers. Therefore, Tris buffers were 
prepared by using water that has been treated with DEPC first. Standard stock 
solutions like EDTA, Tris, TAE, TBE, TE, PBS, SDS, SSC, NaOAc and culture 
media like LB and SOC were prepared as described in Table 1. All solutions 
used are named in the text. 
 
3.3 Equipment 
General lab equipment was used for the molecular and cell biology techniques, 
including balances, centrifuges, electrophoresis equipment, heating blocks and 
plates, hybridization and incubation ovens, micropipettes, PCR and gradient 
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thermocyclers, pH meter, shakers, sterile hood, UV-transilluminator, vortexes 
and waterbaths. Fresh frozen sections were obtained using the Cryostat CM 
1900, Leica (Leica, Solms Germany).  
Zeiss AxioScipe AX 1.0 microscope (Carl Zeiss, Jena, Germany) with AxioCam 
MC5 and AxioVision software was used to collect fluorescent microscopic 
images. Leica microscope DM RA2 (Leica Camera AG) attached to a Leica 
DC300 F camera for light microscopic images. 
  
3.4 Molecular Biological Techniques 
 
3.4.1 Isolation and Purification of DNA and RNA 
a) Isolation of Genomic DNA 
Genomic DNA was isolated from adults N. furzeri. The brains were rapidly 
excised from anesthetized animals and frozen in liquid nitrogen and pulverized. 
After addition of lysis buffer (0.1 M Tris/HCl, 0.2 M NaCl, 5 mM EDTA, 0.2% 
w/v SDS, pH 8.5) and proteinase K (150 μg/ml), the tissue was incubated under 
continuous rotation at 55°C overnight. Undissolved material was pelleted. After 
a phenol/chloroform extraction the DNA was precipitated using 1/10 volume of 
3 M NaOAc (pH5.2) and 2 volumes of 100% ethanol. The DNA was washed 
two times with 70% ethanol, dried and dissolved in 100-500 μl H2O at 4°C 
overnight. 
 
b) Isolation of tissue specific RNA 
Total RNA was extracted from the brains of adult N. furzeri using 
INVITROGEN Trizol following the manufacturer instructions. The tissues were 
centrifuged and homogenized at 4°C per 10 min at 12000 rpm. RNA, present in 
the aqueous phase, was transferred in a 1.5 ml sterile tube and precipitation was 
carried out by adding 0.5 ml isopropyl alcohol and centrifuging the sample at 
4°C per 15 min at 12000 rpm. The pellet, containing the RNA, was resuspended 
in 100 µl of RNAse-free H2O and stored at -80°C.   
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3.4.2 Polymerase Chain Reactions (PCR) 
Polymerase chain reactions were performed for different purposes like 
subcloning of DNA fragments, identification of positive clones and 
determination of insert sizes in colony PCRs, preparing of a template for in vitro 
transcription and sequencing. Primers were designed according to standard 
methods using the Primer3 software. Different  cycles conditions were used, 
according to the different purposes. 
 
3.4.3 Oligonucleotide Primers 
Oligonucleotide primers were purchased from MWG. The primers were 
delivered or dissolved at standard concentration of 100 mM. Working dilutions 
were prepared at concentration of 10 mM and stored at -20°C. All used are listed 
below: sequence(5'_3') T (°C) Supplier Purpose : 
M13-Fwd  GTAAAACGACGGCCAGT,  
M13-Rev  AACAGCTATGACCATG,  
BDNF Fw  ATGACCATCCTGTTC(C/G=S)TTACTA 
BDNF Rev AAGACGGC(G/C/A=V)ATAGACATGTC 
 
3.4.4 RT- PCR (first-strand reaction) 
The isolated and purified RNA was used to synthesize the first filament of 
cDNA by using the kit SuperScript™ II Reverse Transcriptase (Invitrogen Life 
Technologies; New York, USA), according to the manufacturer instructions. The 
reaction mixture was prepared using 8 μl DNAse-treated RNA, 15 μl DEPC 
treated H2O and 2.3 μl pdN6 (100 ng/μl), and incubated 10 min at 70°C and, 
then, cooled on ice for 2 min. To start the reaction, 9 μl of reverse transcriptase 
buffer (5x Superscript II, Invitrogen Life Technologies), 2.3 μl dNTP and 4.5 μl 
dithiothreitol (0.1 M) were added and incubated first at 25°C for 10 min and then 
at 42°C for 2 min. The reaction was started by addition of 2.3 μl (460 U) reverse 
transcriptase Superscript II (Invitrogen Life Technologies) and synthesis was 
allowed at 42°C for 50 min. The inactivating of reverse transcriptase for 15 min 
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at 70°C stopped the transcription. 2 μl of this product was directly used for PCR 
reactions. 
 
 
3.4.5 Amplification of cDNA (second-strand reaction) 
The reaction mixture was made of a final volume of 25µl, including TE buffer 
10x, 0.25 U di Taq DNA polymerase, 1.5 mM MgCl2, 0.5 lM of dNTPs, 0.5 lM 
of forward and reverse primers (see above) and 1µl of cDNA template obtained 
from the retro-trascription PCR. The primers were designed to amplify a 
fragment of 810 bp of BDNF gene (shown below) cycling and the conditions 
were as follows: 94°C for 1 min,  followed by 35 cycles of  94 °C for 30 s, 55° C 
for 30 s and 72 °C for 1 min. A control reaction was done separately with β-actin 
primers, which yielded a product of 630 bp. The β-actin PCR was performed 
with a sense primer (5′-CTT TTC ACg gTT ggC CTT Agg gTT-3′) and an 
antisense primer (5′-AgA TTA CTg CCC Tgg CTC CTA g-3′) at 94 °C for 4 
min, followed by 29 cycles of 94 °C for 30 s, 60 °C for 45 s and 72 °C for 10 
min. As a negative control, DNAse-treated RNA from brain was screened by 
PCR with BDNF primers to confirm the absence of genomic DNA. This control 
showed that the PCR product was amplified from cDNA and not from residual 
genomic DNA in the brain samples. 
 
810 bp cDNA sequence for N.furzeri BDNF 
ATGACCATCCTGTTCCTTACTATGGTTATTTCATACTTCAGTTGCATGAGAGCTGCGC
CCCTGAGAGACGCCCCGGGCATTCGGGGCCATCGGACGGAAGGCTACTTGGGCGCT
GCTGCGACGACCGCTCGAGGCCACGGGACTCTGCAGAGTGGCGGCGGGCCGGGCCA
GCACGGCGAGCTGCCCTCGCTCACAGACACGTTCGAGCAGGTGATCGAGGAGCTGC
TGGAGGTGGAGGGAGAGGCCGCACAGCTGGGTCAGGGGTCCGACAAGAGCCAGGG
AGGCGGGGGCCCGTTGCCCGTGGTCACCACAGAGAACAAGGATGTCGACCTGTACA
ACTCGCGGGTGATGATCAGCAACCAAGTGCCTTTGGAGCCGCCGTTGCTCTTTCTTC
TGGAGGAATACAAAAACTATCTGGATGCTGCAAACATGTCCATGAGGGTGAGGCGA
CACTCCGACCCCTCACGGCGTGGAGAGCTGAGTGTGTGTGACAGTATTAGCCAGTG
GGTGACAGCTGTGGATAAAAAGACGGCAATAGACATGTCCGGGCAGACAGTTACCG
TCATGGAAAAGGTCCCTGTCCCCAATGGCCAGCTGAAGCAATACTTTTATGAGACCA
AATGCAACCCCATGGGGTACACAAAGGACGGCTGCAGAGGAATAGACAAGCGGCA
TTATAACTCCCAATGCAGGACAACCCAGTCCTACGTGCGAGCGCTCACCATGGATAG
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CAAAAAGAAGATTGGCTGGCGGTTTATAAGGATAGACACTTCATGTGTATGCACATT
GACCATTAAAAGAGGGAGAT 
 
 
3.4.6 Agarose Gel Electrophoresis 
RNA and DNA were loaded on 1% agarose gels containing 0.5 μg/ml ethidium 
bromide in 1 x TAE Buffer and run at 5-10 V/cm. Genomic DNA was loaded on 
low concentration agarose gels (1%) gel and run slowly (1-2 V/cm) to ensure 
better separation and to avoid smearing the DNA. The loading dye used was 
purchased from Bioline. The DNA-HyperLadder I Bioline was used for 
estimation of molecular weight.  
 
3.4.7 In situ hybridization 
 
3.4.7.1 Synthesis of BDNF riboprobe 
a) Cloning of BDNF gene 
PCR products were cloned using pGEM®-T and Easy Vector Systems Technical 
Manual (Promega; Madison, WI, USA)  following the manufacturer instructions.  
   
b) Cleaning PCR products 
PCR products were cleaned up by using  the kit NucleoSpin
®
 Extract II 
(MACHEREY-NAGEL GmbH & Co, Düren, Germany). DNA was purified 
from contaminations like salts and soluble macromolecular components, which 
were removed by a simple washing step with ethanolic Wash Buffer NT3. Pure 
DNA was finally eluted under low ionic strength conditions with slightly 
alkaline Elution Buffer NE. 
 
c) Ligation of DNA Fragments and PCR Products 
Ligation reactions were used to combine vector and insert DNA. For this 
purpose, purified insert DNA was ligated to dephosphorylated vector DNA using 
T4 DNA ligase (pGEM-T) according to the supplier‟s instructions. PCR 
products (3 μl) were ligated directly into the pGEM-T (Promega) vector 
according to the manufacturer's instructions. 
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d) Transformation of ligation reactions into competent cells 
The transformation reaction was carried out following the supplier instructions. 
Ligation reactions were transferred into high-efficiency competent cells (E. coli 
DH5α; Invitrogen), and the appropriate protocol was followed. After heat shock, 
the bacteria were plated onto LB agar plates containing the appropriate antibiotic 
to select only the transformed bacteria. Transformants were screened, and the 
white colonies containing the insert were then cultivated. 
 
e) Colony PCR and Mini-prep 
Single bacterial colonies were picked and inoculated in LB medium containing 
the appropriate antibiotic plates. The bacteria were grown for one to three hours 
in an orbital rotator at 37°C. 5 μl of bacterial suspension was used as a template 
in a PCR reaction. All PCR reactions were carried out in a final volume of 20 μl 
containing 1 x PCR buffer, 1.25 mM MgCl2, 10 pmoles of each primer, 0.1 mM 
of each dNTP, 1 U of Taq DNA polymerase (QIAGEN). Generally M13 primers 
or other vector primers like T3 and T7 primers were used.  
PCR conditions were as follows : 1 cycle at 95°C per 5 min, at 95°C per 1 min, 
30 cycles sub-divided at 54°C per 1.5 min, at 72°C per 1 min, 1 cycle at 72°C 5 
min.  
Clones that were positive in the PCR were used to inoculate 3 ml of LB medium. 
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Some of the clones were then used for a mini-preparation, which was carried out 
by the ZR Plasmid Miniprep™- Classic applying the manufacturer instructions. 
 
f) Sequencing 
Plasmidic DNA sequencing was carried out at the Laboratory of Genome 
analysis (Platzer Laboratory), FLI- Leibniz Institute for Age Research. Sequence 
analysis was carried out using BLAST (Basic Local Alignment Search Tool), 
accessed through http://genome.fli-leibniz.de/world_nf_blast/world_blast_nf.pl. 
Alignments of the sequences with several closely related genes were carried out 
subsequently. 
 
g) In vitro transcription of riboprobes 
Antisense and sense RNA probes labeled with digoxigenin (DIG) were 
generated by in vitro transcription according to the manufacturer's instructions 
(ROCHE). Plasmids were linearized by digestion. Restriction enzymes used 
were from New England Biolabs. Digestions were performed using about 200 ng 
of plasmid in 1 x restriction enzyme digestion buffer and 6 U of restriction 
enzyme in a total volume of 20 μl. Digestion mixtures were incubated for 1-2 h 
at the appropriate temperatures for each enzyme as suggested by the 
manufacturer. Digestion products were controlled by electrophoresis analysis on 
agarose gel. Successively, protease K (50 µg/ml) and SDS 1% were added to the 
digested products and an incubation at 45°C per 30 min. After the extraction 
with phenol-chloroform-isoamylalcohol (PCI = 25:24:1), the aqueous phase was 
then extracted using 200 μl chloroform. The aqueous phase, containing the 
DNA, was then ethanol precipitated  using 0.3 M sodium acetate and two to 
three volumes of ice-cold absolute ethanol. Precipitation was allowed at -20°C 
for 30 min or at -80°C for 10 min. After centrifugation at maximum speed at 4°C 
for 30 min, the pellets were washed with 70% ethanol air-dried and re-suspended 
in the appropriate buffer. BDNF RNA riboprobe was generated by linearization 
with a restriction enzyme .  
For transcription, T7 and SP6 polymerase promoter sequences in the vector 
backbone were utilized. About 100ng of linearized plasmid template was used 
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for labeling. Transcription buffer and DIG-labeling mixture were added to a 
final concentration of 1 x. 4 U of RNA. 
Polymerase (T7 and SP6) and 20 U of DNAse inhibitor (ROCHE) were also 
added. The reaction was incubated at 38°C for 2 hours and terminated by 
addition of 2 μl of EDTA (200 mM, pH 8.0). The RNA transcript was ethanol 
precipitated and analyzed for size and integrity using agarose gel 
electrophoresis. 
 
3.4.7.2 LNA probe design 
LNA modified DNA oligonucleotides probes, containing an LNA nucleotide at 
every third position, and labeled at the 59 end only, or at the 59 and 39 ends, 
with DIG, were supplied by Exiqon Inc. (Vedbaek  
Denmark). BDNF, NGF, NT-3, NT-4 and NT-6 probes were designed using the 
Primer3 primer design program (Untergasser et al., 2007) and checked using the 
LNA Oligo Optimizer tool on the Exiqon website (www.exiqon.com). Each 
probe sequence was screened against all known N.furzeri sequences using 
BLAST. LNA probes typically show single nucleotide specificity (Kloosterman 
et al., 2006) (see Table 1). Negative controls were mismatch probes, designed 
and synthesized by Exiqon Inc. (Fig 3a,b). 
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Fig 3. Negative controls: LNA probe vs mismatch probe. a. NT-6 LNA probe labeling in the 
optic tectum (OT). b. NT-6 mismatch LNA probe. In blu DAPI counterstaining. Scale bars: a-b = 
100 µm. 
 
  
38 
 
Table 1. LNA Probes for mRNA detection 
 
Target mRNA     5'-Mod     Synthesis sequence (5'-3')       3'-Mod 
 
      NGF                         DIG           ACGCTAACACTTTCACACACAGA            DIG 
      BDNF                      DIG           ATACTGTCACACACACTCAGCT                DIG  
      NT-3                        DIG           TGAGAGAGTTTAAAGGGTCAGG              DIG  
      NT-4                        DIG           GCAAAACAACAAGACCTCAACAC           DIG 
      NT-6                        DIG           TTGTCTCCTGCTGTCCTGCTCTG               DIG 
     *mut NT-6                DIG           TTGTCTCTCGCTGCTCTGCTTCG              DIG 
 
* mutations are shown bolded 
 
Target NGF mRNA  
ATGAGGTCATCCATGCTGGTCCTGTTCCTCTTCTTCAGTGCCCAGGTAGTGGCCAAC
ATCAGAGGGGACTCGAGCAGCCCCACAACACTGCAGCAGATCAATGCCCACTCCAT
CCCCTCTGTGGACCCAAGCCTCTTCATCAAGCGCCACCATCTCTCCCCCAGGGTGCT
TTTCAGCTCTCAACCTCCTGATGATGAACCAGCAGGGTCGCAAGGGGGCGGCAGAA
GGACCCGCAGGCGAGCAGGACAACCTCAGCACCGCGGGGTATACTCTGTGTGTGAA
AGTGTTAGCGTCTGGGTGGGCAACAAGACCAAAGCCACAGACATCTCGGGCAATGA
GGTGACGGTGCTCCCCGATGTGAACATCAACAATGTCAACAAGAAGCAGTATTTCTT
CGAGACAACGTGTCACAGTTCTCGACCTGGCAGCTCGGGCTGTTTAGGAATCGATGC
GAGACACTGGAACTCCTACTGCACCAACTCACACACTTTTGTTCGAGCGTTGACTTC
ATTCAATGACATGGTGGCGTGGAGGCTCATACGCATCAATGTGGCATGTGTGTGTGT
GCTCAGCCGCAAGTCGTGGCGACAGTGA 
 
Target BDNF mRNA  
ATGACCATCCTGTTCCTTACTATGGTTATTTCATACTTCAGTTGCATGAGAGCTGCGC
CCCTGAGAGACGCCCCGGGCATTCGGGGCCATCGGACGGAAGGCTACTTGGGCGCT
GCTGCGACGACCGCTCGAGGCCACGGGACTCTGCAGAGTGGCGGCGGGCCGGGCCA
GCACGGCGAGCTGCCCTCGCTCACAGACACGTTCGAGCAGGTGATCGAGGAGCTGC
TGGAGGTGGAGGGAGAGGCCGCACAGCTGGGTCAGGGGTCCGACAAGAGCCAGGG
AGGCGGGGGCCCGTTGCCCGTGGTCACCACAGAGAACAAGGATGTCGACCTGTACA
ACTCGCGGGTGATGATCAGCAACCAAGTGCCTTTGGAGCCGCCGTTGCTCTTTCTTC
TGGAGGAATACAAAAACTATCTGGATGCTGCAAACATGTCCATGAGGGTGAGGCGA
CACTCCGACCCCTCACGGCGTGGAGAGCTGAGTGTGTGTGACAGTATTAGCCAGTG
39 
 
GGTGACAGCTGTGGATAAAAAGACGGCAATAGACATGTCCGGGCAGACAGTTACCG
TCATGGAAAAGGTCCCTGTCCCCAATGGCCAGCTGAAGCAATACTTTTATGAGACCA
AATGCAACCCCATGGGGTACACAAAGGACGGCTGCAGAGGAATAGACAAGCGGCA
TTATAACTCCCAATGCAGGACAACCCAGTCCTACGTGCGAGCGCTCACCATGGATAG
CAAAAAGAAGATTGGCTGGCGGTTTATAAGGATAGACACTTCATGTGTATGCACATT
GACCATTAAAAGAGGGAGATAG 
 
Target NT-3 mRNA  
ATGTCCATCCTGCTGTATATGATGTTCCTTGTGTACCTCTATGGTATCCAGGCAACCA
ACATGAACAGCAGCCACCATGGACAGCAGCAGCAGCCAAGTCCTGACCCTTTAAAC
TCTCTCATAATCCAGCTGCTGCAGGCTGATCTGACCAGAGGGAGGACCCGGGGGAA
CTACAGCCAGCAGGGAAAAAGCAGGGATATGGCCCTGCAGGAAACACTGCCTCCTC
TCCCTGATGTGGAGCACTGGGGATCCTGGGGTCGTAGCGGCGGTAGCAGTGACGGT
GCCGTCGAGCAACAGGTGATGCTGTTAAACTCAGATCTCCTCAGGAAGCAGAAGCA
ATACAGTTCACCTCGGGTGCTGCTGAGCGACCGGCCACCACTACAGCCACCGCCGCT
CTACTCAGCTGATGACTTTGTAAGCGGTGGACCAGACAGGGGCGCAATGGGGAACA
GGACGCGTAGGAAGCGCAACACTGGACACAGGAGCTACCGTGGGGAATATTCTGTC
TGCGACAGTGAGAGCCAGTGGGTGACGGACAAAGACCACGCCGTGGACACCAAAG
GAGAACCCGTGATTGTTCTAGCCAAAATCAAAACTAGCGCCACGCAGGACGTCAGA
CAATTCTTTTACGAGACGCGCTGTCGGACCCCGGGAACCAGTAAAGGAGGCTGCAG
GGGGATCGATGACAAGAACTGGAATTCTCAATGCAAGACGACACAGACGTATGTCC
GAGCCCTAACACAGGCTCAGAATAAAGTGGGATGGAGGTGGATACGCATAGACACT
TCCTGTGTGTGTGCATTGTCACGGAAACGCCGTAAGACGTAA 
 
Target NT-4 mRNA  
GGATACAAAGATCTTTTATTACATGTCCGACTGAACACAACAGCAGGTTTTCTTCAG
GTGTCACTTAATTTACAAACCACATAGTTTCATGTTCTTGAACCACATTTGAGGAGT
CCCACATACGCAATCTGACACAAATTATAGTTTGTTCTGAATACATTCCCCTTTGCA
ACATTCATAAGAGTTTGGAGCTGTAAAATAAACTGTCAGTAGGTGGCGCTCTTTGTT
TTTAGAAAAACACAGCAAGCCAAAGGCTGGAATTATCATCAGACACTGGAGAGACT
GCTGCGTGAAGACGTCTTCTATAAATACACACTGAAATACATAAGGGTATACTGGTG
TCATGTTATACACACGTTAAGGAATATATTAATATCAAAGACATGCTTACATAATAA
TCAAAGATAACTTAGATTATGAAAAGTAGGTCATACAAAACAGTACTTCTTGATGTA
AAATCTATAAAACAAATTTCCCTAAGGTCTAGTGTTGAGGTCTTGTTGTTTTGCAAA
AGTCTCATGGTTGAGGGAGGGGAAATCCAGAGATGTGGGGGAAAGTGAACAAGAG
CAGGGCTACTGTACACAGAAGAACATCTCAGTTTCTCTGTGCCCCCATTTTATCCTCT
CCCCCGGGTCAAAACCTCCTTCTTTGTTCTGGACAGCAGCACGCAGACGCAGGACGA
GTCGATTCGGATCCACTGCCATCCGATTTGGTTCCTTTCGTTTCTAATTAGTGCTCGA
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ACAAACGACTGCTTGACCTTGCACTCGCTCCTCCACTGTTTTTTATCCACACCCAAAC
ATCCAGCTCCGGATACGCCCGTCCCCACCGACCTCCCTGT 
 
Target NT-6 mRNA  
CTGGTTTCTGCTCCTCCTGATCGGCGTCCAGGCTGTACTGAACATGGGTGGTGGGTT
CGGCCCGAAGTGCTGGGGCGGCCAATCGCAGAGCAGGACAGCAGGAGACAACAGC
CAGGGACCACCTTTCTCAGGACCACACTTTGCAGCAGCATCATAGGACCACCCACCA
CAGGACCAAGAGGCCTCATCGAGCAGCTTCAAACACACAGAACAGGAGTCCAGTTG
TTGGGCGTTCCGCTGCGGGTTCCTCATTCGACCTTTCAAGTCCAGTGGTAGACCCCA
AGCTCTTCTCTAAGAGACGATACCGTCCCTCGCCCCGTGTTGTCTTCAGTGAGGTGC
CCCCATCCCACGATGCCCTGGAAGGAGAGGGCTATGACATTGAAGGAGTCAAGGAG
GTGAGGGTGCGGCGCAGAGCAGGATCACACATCATGCACAGAGGGGAGTACTCAGT
GTGTGACAGCATAAACACCTGGGTGGGAAACCTGACACGAGCCACAGACATAGCTG
GGAATGAAGTGACCGTGCTCCCCAACGTTACAATCAACAACGTGGTCAAGAAACAG
TTCTTCTATGAGACCACCTGTCGATCCCCCACACACAGGGGCACTGGGGCTGCGAAT
GGGAGCCGGCCTGGAGGACGGGGCGGAAAACAAGGCTCAAAATCCAGCACCTCAG
GTTGCCTTGGCATTGACAGTCGCCACTGGAACTCCCACTGCACCAACACA 
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3.5 Histological Techniques 
 
3.5.1 ISH on brain cryosections 
In situ hybridization was used to determine the cellular localization of specific 
messages within cell populations of the central nervous system of N. furzeri. 
Two appropriate protocols were followed, respectively for riboprobe and LNA 
probes. 
 
a) ISH for BDNF riboprobe 
The brains were rapidly excised from anesthetized animals, fixed in PFA 4% for 
24 hours at 4°C. Successively, brains were incubated in saccharose solution at 
30% overnight at 4°C and saccharose solution at 20% overnight at 4°C. The 
brains, then, were embedded in cryomounting  and frozen at –80°C. Serially 
transversal, horizontal and sagittal sections were cut at cryostat (Leica). 
Brain sections of 14 μm thickness were washed in PBS 0.1% Tween 20 (PBT). 
All buffers are listed in Table 2.  
The permeabilization consisted of incubation for 5 min in 2.3% sodium 
borohydride in 0.1 M Tris–HCl (pH 7.5), followed by 1 mg/ml Proteinase K 
(Sigma–Aldrich) for 10 min at room temperature (RT). After washing in glycine 
and PBT, the sections were fixed in 4% PFA in PBS for 15 min at RT. 
Thereafter, the prehybridization was carried out in a hybridization solution 
containing 50% formamide, 0.5% SSC, 500 µg/ml Heparin, 50 µg/ml yeast 
RNA, 0.1% Tween 20 at 55 °C for 1 h. Probes were denatured for 10 min at 80 
°C and sections were then incubated, in hybridization solution containing either 
antisense and sense BDNF probe at a concentration of 2 ng/µg, overnight at 
55°C. RNAse free conditions were kept during all prehybridization and 
hybridization steps. Post-hybridization washes were carried out at 55°C as 
follows: 2 x 20 min in 1x SSC, 2 x 10 min in 0.5 x SSC, and then in PBT at RT. 
The sections were blocked in blocking solution containing 10% normal goat 
serum and blocking reagent (Roche, Germany) for 1 h at RT. After, sections 
were incubated in fresh blocking buffer containing a 1:2000 dilution of anti-
digoxigenin Fab fragments conjugated with alkaline posphatase (Roche) and 
blocking solution, overnight at 4°C. The sections were washed in PBT 5 x 5 min 
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and in PBT + Levamisol (5mM) 3 x 5 at RT. The chromogenic reactions was 
carried out by using Fast Red tablets (Sigma-Aldrich) in Tris buffer and 
incubating the slides at RT for 3-4 h, in the dark. After the signal was developed, 
the sections were washed in PBT 3 x 5 min at RT, and mounted with 
Vectashield (VECTOR) contains DAPI that is used as counterstaining for the 
nuclei.   
 
b) ISH for LNA probes 
The protocol followed for ISH using LNA probes included only few different 
steps compared to that applied for the BDNF riboprobe. The prehybridization 
and the hybridization steps were carried out at 42°C. Post-hybridization washes 
were carried out as follows: 2 x 20 min in 1x SSC at room temperature, 2 x 10 
min in 0.5 x SSC at RT. 
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Table 2.  Buffers preparation  
 
 
  
 
TAE 50x 
Tris Base                     242 gr 
Acetic Acid              57.1 mL  
EDTA 0.5 M             100mL  
 
TBE 10x (1 l) 
 
Tris                              108gr 
  Boric acid                      55gr 
  EDTA 0,5 M                40ml  
  (pH 8,0)   
TE 
 
Tris-HCl (pH 8,0)     10mM 
 EDTA                        1mM 
TRIS 10x      pH 7.6 
 
Trizma base                 61gr 
 Distilled H2O                1 l 
LB –Luria Bertani 
medium (1 l) 
 
NaCl                             10gr 
Bacto-Triptone             10gr 
Yeast extract                  5gr 
 
 
SOB 
Trypton                        20gr            
Yeast extract                  5gr 
NaCl                              5 M 
KCl                                1 M 
H2O                     up to 1 liter 
 
SOC 
 
Add to SOB for 1 liter  
 MgSO4 1 M               10ml 
 MgCl2                                        10ml 
 Glucosio 1M               20ml 
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   DEPC H20 0,1% (1 l) 
 
Distilled H20                    1 l 
Diethylpirocarbonate  100 µl 
PBS 
Tablets Sigma-Aldrich 
 DEPC H20 1l  
 PBS tablets  5 
 
PBST 
 
DEPC H20                   200 µl  
PBS tablet                        1 
Tween-20                     100 µl 
Glycine in PBT 
 
DEPC H20                   200 µl  
Glycine                           2  gr 
LB –Luria Bertani medium 
(1 l) 
 
NaCl                              10 gr 
Bacto-Triptone              10 gr 
Yeast extract                   5 gr 
 
SSC 20% pH 7.0 
 
DEPC H20                  500 ml 
NaCl                               3 M 
Na3Citrate                 300 mM 
 
 
Blocking solution  
 
PBS                                1x 
Goat serum                  10% 
(heat inactivated)  
Blocking Reagent       0,5% 
Tween-20                   0,1% 
H20 up to the final volume  
 
 
 
Hybridization Buffer  
 
Formamide                       50% 
SSC                                    5x 
Tween-20                         0,1% 
Citric-Acid                     9,2mM 
Heparin                         50µg/ml 
Yeast t-RNA               500µg/ml 
DEPC H20             up to the final   
                                         volume 
45 
 
3.5.2 IHC  
a) Antibody Staining on Fresh Frozen Cryostat Sections 
The collectioning samples and subsequent treatment procedures have been 
described in the paragraph n° 3.5.1.  
Sections of 14 µm thickness were cut in transverse, horizontal and sagittal 
orientation. Sections were fixed in 4% PFA for 10-20 min at RT and washed 
three times  for 10 min at RT each in PBS 1x (pH 7.5). Tissue in the slides was 
then dried by incubation in aceton for 15 min at RT. The slides were washed 3 x 
for 5 min in PBST (PBS + 0.1% TritonX-100). Then, they were placed in target 
retrieval solution (Citric buffer pH 7.4) brought to boil using the microwave, and 
then gently boiled for 10 min at 10% power, left in the solution to cool for 30 
min. Sections were washed with PBS and incubated for 1 h at RT in a solution of 
PBS with 20% NGS (S1000; VECTOR Lab; Burlingame, CA), 1% BSA, and 
0.1% TritonX-100. Primary antibodies are shown in Table 3. Then, they were 
incubated in a humid chamber for 24 h at 4°C with each of primary antibody 
diluted with PBS containing 0.2% TritonX-100, 0.1% bovine serum albumin, 
and 4% normal goat serum. Incubation with primary antibody was carried out 
overnight at 4°C. After incubation, the sections were washed in PBS 1x and 
incubated with EnVision for 30 min at RT. After washing, the immunoreactive 
sites were visualized using a fresh solution of 10 µg of DAB in 15 ml of a 0.5 M 
Tris buffer, pH 7.6, containing 1.5 ml of 0.03% H2O2.  
 
b) Antibody staining on paraffin sections 
After anesthesia, animals were decapitated and the heads were fixed in Bouin‟s 
fluid for 24 h at RT, washed in alcohol 50% and then progressively dehydrated 
and embedded in paraffin wax. 
Microtomical sections of 7 µm thickness were cut in transverse, horizontal and 
sagittal orientation. After dewaxing in xylene and dehydrating in progressively 
diluted alcohols, serial sections were treated with 3% H2O2 per 20 min, washed 
with PBS 1x  and incubated in a humid chamber for 24 h at 4°C with each of 
primary antibody diluted with PBS 1x containing 0.2% TritonX-100, 0.1% 
bovine serum albumin, and 4% normal goat serum (NGS). 
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Primary antibodies are shown in Table 3. After incubation, the sections were 
washed in PBS and treated by using EnVision method: the sections were 
incubated with EnVision for 30 min at RT. After washing in PBS 1x, the 
immunoreactive sites were visualized using a fresh solution of 10 µg of 3,30-
diaminobenzidine tetrahydrochloride (DAB) (D5905; Sigma-Aldrich) in 15 ml 
of a 0.5 M Tris buffer, pH 7.6, containing 1.5 ml of 0.03% H2O2.  
 
c) Controls 
The specificity of the each immunohistochemical reaction was checked in 
repeated trials as follows: 1) substitution of either the primary antibody or the 
antirabbit IgG or the EnVision by PBS or non-immune serum; 2) preabsorption 
of the primary antibodies with homologous antigens (up to 50 mg/ml antiserum 
in the final dilution) or correlated antigens (up to 100 mg/ml antiserum in the 
final dilution). The peptides used in the preabsorption were sc-548P, sc-546P, 
sc-547P, sc-545P (Santa Cruz) for NGF, BDNF, NT-3, NT-4 respectively.  
 
Table 3. Primary antisera 
Antisera Source Host Characteristics Dilution 
 
BDNF 
 
sc-546 
Santa Cruz 
Biotechnology 
 
Rabbit 
Internal region of 
BDNF of human 
origin 
 
1:150 
 
BDNF 
ab6201 
Abcam 
 
Rabbit 
Recombinant full 
length protein 
(Human) 
 
1:150 
 
NGF 
sc-548 
Santa Cruz 
Biotechnology 
 
Rabbit 
N-terminus of the 
mature chain of 
NGF of human 
origin 
 
1:150 
 
NT-3 
sc-547 
Santa Cruz 
Biotechnology 
 
Rabbit 
 internal region of 
NT-3 of human 
origin   
 
1:150 
 
NT-4 
sc-545 
Santa Cruz 
Biotechnology 
 
Rabbit 
internal region of 
NT-4 of human 
origin 
 
1:150 
Anti-
Digoxigenin-
AP 
FAB 
Fragments 
 
 
Roche 
 
 
Sheep 
  
 
1:2000 
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3.5.3 Histochemical Techniques 
Luxol Fast-Bleu/Cresyl Violet Staining  
The collectioning samples and subsequent treatment procedures have been 
described in the paragraph n° 3.5.2b. Microtomical sections of 7 µm thickness 
were cut in transverse, horizontal and sagittal orientation and employed for the  
Luxol Fast-Bleu/Cresyl Violet staining. 
After removing paraffin, the sections were rinsed with distilled water, and 
immersed in acetic acid solution (approximately 20 drops of 10% acetic acid in 
100 ml of distillated water) for 5 min, and in 95% ethanol. The sections were, 
then, incubated in Luxol Fast Blue MSB (LFB; Chroma-Gesellschaft, Könger, 
Germany) solution (1g LFB in 1000 ml of 95 % ethanol) for 24 h at 37°C. After 
rinsing in 95% ethanol, followed by distilled water, they were differentiated in 
0,05% lithium carbonate for few seconds at RT, and immersed in 70% ethanol 5 
times. The sections were subsequently incubated in Cresyl Violet (CV; 
Katayamakagaku, Tokyo, Japan) solution (0,1 g CV and a few drops of 10% 
acetic acid in 10 ml of distilled water, then filtered prior to incubation) for 
approximately 30 min at RT. After rinsing in distilled water, they were 
dehydrated with ethanol series, cleared with xylene, and coverslipped. 
 
3.6 Phylogenetic Analysis 
Phylogenetic analysis was performed by MEGA5 (Tamura et al., 2011). All 
genes and amino acid sequences were downloaded from ENSEMBL aligned 
using ClustaW, and the alignment manually inspected. Several different 
algorithms and substitutions models were tested and all retrieved the same 
topology. Results of the Neighbough-Joining Method (NJ) are illustrated. 
Interior branch test was used to calculate the support for the branches. 
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4. RESULTS 
 
4.1 Atlas of  the brain of Nothobranchius furzeri 
Schematic drawings (Fig 4) of the macroscopical aspect of the encephalon of N. 
furzeri have been done, since the brain structures of teleosts presents enormous 
interspecific diversity with regards to the morphology (Ito, 1978; Nieuwenhuys 
et al., 1997). The diversity exists even among strains of the same species 
(Ishikawa et al., 1999). For example, inbred strains of medaka with different 
genotypes possess large variation in gross brain morphology (Ishikawa et al., 
1999). Furthermore, taking into consideration the high interspecificity among 
fish and some peculiar features, which were noticed during the experimental 
procedures, an atlas of the CNS of N. furzeri, has been schematically constructed 
(Fig 4,5a-y), indicating the main encephalic regions in serial transverse sections. 
The abbreviations list of figured is annexed. This abbreviations list will be 
apllied also to ISH and IHC results.  
The used strain for the description is an inbred strain, long-lived phenotype.  
The brain structures were identified mainly based on comparative and 
hodological information on other Cyprinodontiformes, i.e. Fundulus heteroclitus 
(Peter et al., 1975); Xiphophorus helleri (Anken and Rahmann; 1994), and 
Atherinomorphes, i.e. Oryzia latipes (Ishikawa et al., 1999).   
The nomenclature of the identified nuclei and the fiber tracts corresponds to 
Anken and Rahmann (1994) and Nieuwenhuys (1997).  
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Fig 4. Dorsal (A), ventral (B) and left lateral (C) view of the gross anatomy of brain of N. 
furzeri. Drawings by Massimo Demma ©. 
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Fig 5. Cranio-caudal transverse  sections of N. furzeri brain. a-j forebrain; k-r 
midbrain; s-y hindbrain. Scale bars a-y =200µm   
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Abbreviations 
 
AC    anterior commissure 
AOL     octavolateral area 
AP    pretectal area  
AT    anterior thalamic nucleus 
Bc                              conjuntival brachium 
Can    commissure ansulata 
cc    cerebellar crista 
CC    corpus of cerebellum 
CH    horizontal commissure 
Ci                                      interpeduncolar corpus 
CM    mammillary corpus  
Crv    ventral rhombencephalic commissure 
Cttd    decussation of cerebello-tectal tract 
DcT    dorso- central area of telencephalon  
DdT    dorso-dorsal area of telencephalon 
DIL    inferior diffuse lobe of hypothalamus 
DllT    dorso-lateral area of lateral  telencephalon 
DlT    dorso-lateral area of  telencephalon 
DmT    dorso-medial area of  telencephalon 
DOT    dorsal optic tract 
DPT    dorsal posterior thalamic nucleus 
DpT    dorso- posterior area of telencephalon 
ecl    external cell layer 
eg    granular eminentiae 
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EN     entopeduncular nucleus 
ENa    entopeduncolar area 
EW    Edinger-Westphal nucleus 
farci    internal arcuate fibers 
flb    lateral forebrain bundle 
Fll    lateral longitudinal fascicle 
Flm    medial longitudinal fascicle 
FR    retroflex fascicle 
gc    central griseum 
Gl    glomerular layer of olphactory bulbs 
gl    granular layer of cerebellum 
H    habenular nucleus 
HC    caudal hypothalamus 
HD    dorsal hypothalamus 
Hr    hypothalamic recess 
HV    ventral hypothalamus 
icl    internal cell layer 
II    nerve II 
III    nerve III  
IV    nerve IV  
IXm    nerve IX (motor branch) 
IXs    nerve IX (sensory branch) 
LV    lateral nucleus of cerebellar valvula 
mes velum   mesencephalic velum  
ml    molecular layer of cerebellum 
MOT    medial optic tract 
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mv    mesencephalic ventricle 
NC    central nucleus 
NDTL               diffuse nucleus of lateral torus  
NFlm    nucleus of medial longitudinal fascicle 
NG    glomerular nucleus 
NGa    glomerular nucleus anterior part 
NI                                          isthmic nucleus 
NIII    nucleus of III nerve 
NIV    nucleus of IV nerve 
NLlf    nucleus of lateral longitudinal fascicle 
NR    red nucleus 
NRP    posterior recess nucleus 
NSF    nucleus of solitary fascicle 
NT    taenia nucleus 
NV    nucleus of nerve V 
NX    nerve X 
OB    olphactory bulbs 
OT    optic tectum  
PC    posterior commessure 
Pc    pretectal nucleus central part 
Pcl    Purkinje cells layer 
Pd    pretectal nucleus dorsal part 
PG    preglomerular nucleus 
PGp    preglomerular nucleus posterior part 
PGZ    periglomerular grey zone 
Pi    pretectal nucleus intermedial part 
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PO    paraventricolar organ 
Pp    pretectal nucleus periventricular part 
PPa    anterior preoptic nucleus  
PPm    preoptic nucleus magnocellular portion   
PPp    preoptic nucleus parvocellular portion 
Pv    pretectal nucleus ventral part 
ra    nucleus of raphe  
RFa    anterior reticular formation 
RFi    intermedial reticular formation 
RFm    mesencephalic reticular formation 
RFp    posterior reticular formation 
rv    rhombencephalic ventricle 
SC    suprachiasmatic nucleus 
Tbr    bulbo-reticular tract 
Tbs    bulbo-spinal tract 
Tbt    tecto-bulbar tract 
Tc    cerebellar tract 
Td    dorsal tegmental nucleus 
TL    longitudinal tori 
TN    tuberal nucleus 
TNa     tuberal nucleus anterior part 
TS    semicircular tori 
Tts    tecto-spinal tract 
TV    tract of V nerve 
VC    valvula of cerebellum 
VdT    ventro-dorsal telencephalic area 
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VII    nerve VII 
VIII    nerve VIII 
VlT    ventro-lateral area of  telencephalon 
VLT    ventro-lateral thalamic nucleus 
VMT    ventro-medial thalamic nucleus 
VOT    ventral optic tract 
VpT    ventro-posterior area of telencephalon 
VTN    ventral thalamic nucleus 
VvT    ventro-ventral area of  telencephalon 
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4.2 BDNF 
 
4.2.1 ISH 
ISH experiments were performed by using two probes, riboprobe and LNA 
probe. The patterns of expression of the two probes  did not show differences in 
the anatomical distribution. Therefore, the present results report a unique 
neuroanatomical description of BDNF mRNA (Table 4).   
 
Telencephalon 
In the olphactory bulbs, some small and round cells in the primary olphactory 
nerve layer and in both external and internal layers were labeled (Fig 6a). The 
dorsal area of telencephalon showed a peculiar pattern of distribution of mRNA 
BDNF expressing neurons: numerous round small neurons, organized in layers 
in the most rostral part (Fig 6b), and less numerous and grouped in the most 
caudal part. Specifically, in the dorso-lateral and dorso-medial areas (Fig 6c) 
weakly stained neurons were seen. In the dorso-central telencephalic area (Fig 
6c') an isolated group of neurons expressing  BDNF were detected. In the ventral 
areas, mainly in the ventro-ventral area,  few neurons were labeled. Along the 
surface of telencephalic ventricle the expression of BDNF was observed in small 
cells.     
 
Diencephalon 
In the most rostral part of the diencephalon, the preoptic area, the expression of 
BDNF mRNA was observed in neurons belonging to the parvocellular and 
magnocellular preoptic nuclei (Fig 6d) and to the suprachiasmatic nucleus (Fig 
6d). In the epithalamus, the symmetric habenular nuclei appeared moderately 
labeled. In the thalamus, dorso-medially, strong labeling was observed in the 
anterior and ventral thalamic nuclei (Fig 6e) and in the intermediate one.  
In the hypothalamus, small packed neurons, belonging to the dorsal and ventral 
hypothalamic nuclei (Fig 6f), were strongly labeled. Moreover, an intense 
staining was also observed in the anterior tuberal nucleus. More posteriorly, in 
the diffuse nucleus of inferior lobe grouped large neurons, expressing BDNF 
mRNA, were observed. 
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In the pretectum, strong positivity was observed in large neurons of  the central 
nucleus (Fig 6e,g).  
Along the ventricle, glial cells showed BDNF labeling. 
 
Mesencephalon 
Intense labeling of BDNF mRNA was detected in the optic tectum (OT), 
predominantly in the periventricular gray zone (PGZ) (Fig 7a), where numerous 
cells resulted strongly labeled, in the central white and grey zone (CZ) (Fig  7a), 
where sparse and small positive neurons with processes projecting towards the 
external layer. Finally, many small positive cells were also localized on the 
external layer of the superficial white and grey zone (SWGZ) (Fig 7a) of OT. 
A slight staining was detected in the small and packed cells of longitudinal tori 
(Fig 7b). Intense BDNF mRNA expression was seen in the cells  localized 
between the longitudinal tori and OT, (Fig 7b). Along the border of the 
glomerular nucleus (Fig 7c,d) many positive large neurons were detected, and in 
the horizontal commissure some scattered neurons (Fig 7c) were labeled. High 
positivity was seen in grouped neurons of semicircular tori (Fig 7e). Intensely 
labeled small grouped neurons were observed in the dorsal tegmental nucleus 
(Fig 7f). Intensely labeled neurons were detected in the nucleus of longitudinal 
fascicle, whereas some weak positivity was also detected in the fibers of 
longitudinal medial and lateral fascicles. 
Large intensely labeled neurons showing evident cytoplasmatic processes were 
observed in the nucleus of III and V (Fig 7f) cranial nerves. 
 
Rhombencephalon 
In the cerebellum, the BDNF mRNA expression was observed in the Purkinje 
cells in the valvula (Fig 8a,b) and body of cerebellum (Fig 8c,d). Still in the 
body, cells of the granular layer and the radial glia at the uppermost area of the 
body showed BDNF mRNA expression (Fig 8c,d). 
In the medulla oblongata, intense labeling was seen in neurons of the nucleus 
VII cranial nerve, and in small neurons of the nucleus of octavolateral area. 
Some positive fibers were seen in the secondary gustatory tract. Moreover, large 
70 
 
neurons belonging to the anterior, intermediate and posterior reticular formation 
showed high mRNA BDNF expression.  
Along the rhombencephalic ventricle, some positive glial cells were detected.  
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Table 4* 
  
         BDNF ISH 
TELENCEPHALON 
 
olphactory bulbs 
 
primary olfactory fiber layer + 
internal and external cell 
layer 
+ 
dorsal telencephalon 
dorso-lateral + 
dorso-medial ++ 
dorso-central + 
ventral telencephalon ventro-ventral + 
ventricle  + 
DIENCEPHALON 
preoptic area 
preoptic nuclei ++ 
suprachiasmatic nucleus + 
epithalamus habenular nuclei + 
thalamus 
anterior thalamic nucleus +++ 
intermediate thalamic 
nucleus 
++ 
ventral thalamic nucleus ++ 
hypothalamus 
dorsal and ventral 
hypothalamus 
++ 
anterior tuberal nucleus ++ 
diffuse nucleus of inferior 
lobe 
+ 
pretectum area cortical nucleus +++ 
ventricle  + 
MESENCEPHALON 
optic tectum 
PGZ +++ 
CZ + 
SWGZ ++ 
longitudinal tori  +/- 
tegmentum 
glomerular nucleus ++ 
horizontal commissure + 
semicircular tori + 
dorsal tegmental nucleus ++ 
nucleus of longitudinal 
fascicle 
+ 
nucleus of III-V + 
RHOMBENCEPHALON 
cerebellum 
valvula ++ 
body ++ 
medulla oblongata 
nucleus of VII + 
nucleus of octavo-lateral area ++ 
gustatory tract + 
reticular formation 
(anterior, medial and 
posterior) 
 
++ 
ventricle  + 
*  +++ strong; ++ mild; + weak; +/- very weak  
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Fig 6. Expression of BDNF mRNA in the CNS. Transverse forebrain sections. a. BDNF 
mRNA expressed in external (arrowheads) and inner cells layers (arrows) of olphactory bulbs 
(OB). b. BDNF mRNA expressed in round and small neurons, organized in layers, (arrowheads) 
in the most rostral part of telencephalon (Tel). c-c’. BDNF mRNA expressed in the dorso-lateral 
(DlT) and dorso-medial (DmT) telencephalic areas (arrowheads) and in an isolated group of 
neurons in the dorso-central (DcT) telencephalic area (arrow). d. BDNF mRNA expressed in 
neurons of preoptic nuclei, magno- (PPm) and parvocellular (PPp) portions (arrowheads), and in 
neurons of suprachiasmatic nucleus (SC) (arrow). e. BDNF mRNA expressed in neurons of the 
anterior (ATN) and ventral thalamic (VTN) nuclei (arrowheads) and in the central nucleus (NC) 
of the pretectal area (arrow). f. BDNF mRNA expressed in small packed neurons, belonging to 
the dorsal (HD) and ventral (HV) hypothalamic nuclei (arrowheads). g. BDNF mRNA expressed 
in neurons of the central nucleus (NC) (arrowheads). Scale bars: a-d = 100 µm; b-e = 400 µm; c-
f = 200 µm; c’-g = 50 µm.  
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Fig 7. Expression of BDNF mRNA in the CNS. Transverse midbrain sections. a. BDNF 
mRNA expressed in the periventricular gray zone (PGZ) (arrow), in the central white (CZ) and 
grey zone and superficial white and grey zone (SWGZ) (arrowheads). b. BDNF mRNA in the 
small and packed cells of longitudinal tori (TL) (arrowheads) and in the cells and fibers localized 
between the longitudinal tori (TL) and optic tectum (OT) (arrows). c. overview of the expression 
of BDNF in the tegmentum: arrow indicates the expression in neurons of the dorsal tegmental 
nucleus (Td); arrowheads in neurons of the glomerular nucleus (NG) and horizontal commissure 
(CH). d. BDNF mRNA expressed in large neurons along the border of the glomerular nucleus 
(NG) (arrows). e. BDNF mRNA expressed in grouped neurons of the semicircular tori (TS) 
(arrowheads). f. BDNF mRNA expressed in neurons of the dorsal tegmental nucleus (Td) 
(arrows) and of the NV cranial nerve (arrowheads). Scale bars: a-b-d-e-f = 100 µm; c = 400 µm.  
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Fig 8. Expression of BDNF mRNA in the CNS. Transverse hindbrain sections. a. BDNF 
mRNA expressed in Purkinje cells (arrowheads) in the valvula of cerebellum (VC). b. High 
magnification of Purkinje cells in the valvula of cerebellum (VC) expressing mRNA BDNF 
(arrowheads). c. BDNF mRNA expressed in Purkinje cells (arrows) in the body of cerebellum 
(CC), in cells of the granular layer (gl) (arrowheads) and in radial glial cells (asterisks) of the 
body of cerebellum (CC). d. High magnification of Purkinje cells (arrows)  in the body of 
cerebellum (CC) expressing BDNF mRNA and in few small cells of the glomerular layer (gl) 
(arrowhead). Scale bars: a = 200 µm; b = 100 µm; c-d = 50 µm.  
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4.2.2 IHC 
IHC technique was carried out by using two antibodies, to compare whether the 
antigen distribution over the tissue was overlapped. Moreover, experiments with 
each antibody were performed either on paraffin and cryostatic serial sections, in 
order to exclude possible variations due to the fixation methods. The obtained 
results did not show differences in terms of neuronal distribution and intensity of 
immunoreactivity. Therefore, the neuroanatomical description of localization of 
BDNF protein refers to both antibodies, without any discrimination (Table 5).  
 
Telencephalon 
In the telencephalon, the BDNF immunoreactivity (IR) was detected in small 
cells and fibers spread over the olphactory bulbs (Fig 9a); particularly numerous 
immunoreactive fibers were grouped in the glomerular layer (Fig 9a). 
In the telencephalic lobes, BDNF protein was distributed along the most 
superficial layer, the pial margin (Fig 9b), where dense glial cells were stained. 
In the dorso-medial, dorso-central and dorso-lateral (Fig 9b)  areas of the 
telencephalon numerous small neurons resulted intensely positive to BDNF 
protein. Moreover, in the dorso-central area of central telencephalon, grouped 
neurons resulted well stained. Weak immunoreactive fibers were observed in the 
ventrodorsal and ventro-lateral areas of ventral telencephalon. 
 
Diencephalon 
In the diencephalon, BDNF immunoreactive neurons were seen in the 
entopeduncolar nucleus (Fig 9c), and in both magnocellular and parvocellular 
portion of the preoptic nucleus (Fig 9c,d), many neurons were immunoreactive 
to BDNF. Many positive fibers decurring in the medial and lateral forebrain 
bundles were observed. In the epithalamus, packed cells and fibers of the 
habenular nuclei (Fig 9d) were seen BDNF positive. In the thalamus, moderate 
IR was detected in neurons of the anterior and ventral (Fig 9d) thalamic nuclei. 
BDNF IR was also observed in small neurons of  the  paraventricolar organs. 
Most posteriorly, strong BDNF IR was seen in fibers and neurons of  the central 
(Fig 9d) and preglomerular nuclei. In the hypothalamus, immunoreactive fibers 
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were seen in the posterior recess nucleus, and scattered neurons were present in 
the diffuse nucleus of inferior lobe (Fig 9e). 
 
Mesencephalon 
In the OT, many small cells resulted positive to BDNF protein were observe in 
the PGZ (Fig 10a) and numerous fibers and few neurons were positive in the 
layers of CZ and SWGZ (Fig 10a). In the longitudinal tori  (Fig 10b) a BDNF 
fiber mash, intensely stained, was observed. In the glomerular nucleus BDNF IR 
was seen in numerous scattered fibers of the central part of nucleus and in some 
neurons localized at its dorsal and ventral margin (Fig 10c). Moreover, few 
positive neurons were detected in the horizontal commissure. Intense staining 
was observed in the neurons of semicircular tori and dorsal tegmental nucleus 
(Fig 10d). Glial cells localized along the mesencephalic ventricle resulted also 
positive to BDNF. 
 
Rhombencephalon 
In the body of cerebellum, BDNF positivity was observed in the cells of the 
molecular layer and in numerous Purkinje cells. Posterior, in the apical part of 
cerebellum body, strong staining was seen in glial cells. In the medulla 
oblongata, intense BDNF staining was detected in neurons and fibers of the 
solitary fascicle nucleus (Fig 10e,f). Moreover, positivity was seen in dense 
fibers of octavolateral area (Fig 10e) and in the internal arcuate fibers, and in 
neurons of the anterior reticular formation (Fig 10e). 
  
77 
 
 
Table 5* 
BDNF IHC 
TELENCEPHALON 
olphactory bulbs glomerular layer ++ 
 
 
dorsal telencephalon 
 
dorso-dorsal ++ 
dorso-lateral ++ 
dorso-medial ++ 
dorsocentral ++ 
ventral telencephalon ventro-dorsal + 
ventro-lateral + 
DIENCEPHALON 
entopeduncolar 
 nucleus 
 ++ 
 
preoptic area preoptic nuclei ++ 
forebrain bundle medial and lateral + 
epithalamus habenular nuclei + 
 
 
thalamus 
anterior thalamic nucleus + 
ventral thalamic nucleus ++ 
paraventricolar organ + 
cortical nucleus ++ 
preglomerular nucleus ++ 
 
hypothalamus 
posterior recess nucleus + 
diffuse nucleus of inferior 
lobe 
+ 
pretectum area cortical nucleus +++ 
ventricle  + 
MESENCEPHALON 
 
optic tectum 
PGZ + 
CZ +/- 
SWGZ +/- 
longitudinal tori  + 
 
 
tegmentum 
glomerular nucleus ++ 
horizontal commissure +/- 
semicircular tori  
dorsal tegmental nucleus  
ventricle  + 
RHOMBENCEPHALON 
cerebellum body ++ 
 
 
medulla oblongata 
nucleus of solitary fascicle ++ 
nucleus of octavo-lateral 
area 
++ 
internal arcuate fibers + 
reticular formation 
(anterior) 
++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
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Fig 9. Distribution of BDNF antigen in the CNS. Transverse forebrain sections. a. BDNF 
protein distributed in small cells and fibers spread over the olphactory bulbs (OB), particularly 
numerous grouped immunoreactive fibers in the glomerular layer (arrowheads). b-b’. BDNF 
protein distributed in small neurons of dorso-medial (DmT) and dorso-central (DcT) 
telencephalic  areas (arrowheads), and in glial cells along the pial telencephalic margin (arrows). 
c. BDNF protein distributed in neurons of the entopeduncolar nucleus (EN) (arrowheads) and in 
neurons of the preoptic nuclei, magno- (PPm) and parvocellular (PPp) portions (arrows). d. 
BDNF protein distributed in neurons of the preoptic nuclei, magno- (PmN) and parvocellular 
(PpN) portions, and ventral thalamic nucleus (arrowheads), in packed cells and fibers of the 
habenular nuclei (H) and in neurons of the central nucleus (NC) (arrows). e. BDNF protein 
distributed in scattered neurons of the diffuse nucleus of inferior lobe of hypothalamus (DIL) 
(arrows). Scale bars: a-e = 50 µm; b- c’ = 100 µm; b’ = 25 µm; c-d = 200 µm. 
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Fig 10. Distribution of BDNF antigen in the CNS. Transverse midbrain (a-d) and hindbrain 
(e-f) sections. a. BDNF protein distributed in small cells and fibers of the periventricular zone 
(PGZ) (arrows), in numerous fibers and few neurons of  the layers of central zone CZ 
(arrowheads)  and superficial white and grey zone (SWGZ) (arrows) in the OT. b. BDNF protein 
distributed in fiber mash of the longitudinal tori (TL) (arrows). c. BDNF protein distributed in 
neurons along the dorsal and ventral margins of the glomerular nucleus (NG) (arrows). d. BDNF 
protein distributed in neurons of the semicircular tori (TS) (arrows) and dorsal tegmental nucleus 
(Td) (arrowheads). e. BDNF protein distributed in dense fibers of octavolateral area (AOL) 
(arrow), in neurons and fibers of the solitary fascicle nucleus (NSF) (arrows) and in neurons of 
the anterior reticular formation (RFa) (arrowheads). f. High magnification of BDNF protein 
distributed in neurons and fibers of the solitary fascicle nucleus (NFS) (arrows) and in fibers of 
the octavolateral area (AOL) (arrowheads). Scale bars: a-b-f = 50 µm; c-d = 25 µm; e = 100 µm. 
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4.3 NGF 
 
4.3.1 ISH (Table 6) 
Telencephalon 
NGF mRNA was expressed in few cells of the internal cellular layer  and 
glomerular layer of the olphactory bulbs. Labeled small and round cells were 
dispersed among the fibers of the olphactory tract. In the telencephalon, neurons 
were diffusely labeled in the dorsal areas, predominantly in the dorso-central 
area (Fig 11a,b). Additionally, NGF probe signal was detected in the ventral area 
of telencephalon. Particularly, in the ventro-lateral and ventro-ventral areas of 
ventral telencephalon intensely stained cells were seen. In the most posterior 
region of telencephalon, some labeled neurons, belonging to the taenia nucleus, 
were observed (Fig 11c). 
 
Diencephalon 
The nucleus preoptic, both parvo- and magnocellular portion, resulted intensely 
labeled. 
In the epithalamus, packed and small cells located in the ventral part of the 
habenular nuclei expressed NGF mRNA. 
In the most anterior region of thalamus, few and small neurons with some 
evident cytoplasmatic processes were seen in the entopeduncular nucleus. Larger 
few neurons were detected in the anterior and more numerous in ventral thalamic 
nucleus  (Fig 11d).   
In the hypothalamus, the diffuse nucleus of inferior lobe showed a peculiar 
pattern characterized by a continuous line of labeled cells along the margin (Fig 
11e). These cells were small and round in shape. Moreover, few large neurons 
(Fig 11e,f) with evident processess were also labeled in the inner part of the 
inferior diffuse lobe.  
In the most caudal part of diencephalon, positive cells were observed in the 
cortical nucleus. 
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Mesencephalon 
The expression of NGF mRNA was observed in the OT, particularly  in the 
PGZ,  in the layers of  the SWGZ where small cells resulted labeled (Fig 12a) 
and in positive neurons of the CZ (Fig 12a). In the tegmentum of 
mesencephalon, the glomerular nucleus showed intense staining. In the posterior 
portion of the nucleus, few and large positive neurons were localized along the 
ventral margin. More caudally, numerous labeled cells were observed in the 
dorsal tegmental nucleus (Fig 12b). Diffuse positive neurons expressing mRNA 
NGF were detected in the semicircular tori (Fig 12b). Fibers belonging to the 
longitudinal lateral and medial fascicles were also labeled. NGF transcript was 
detected in the neurons of the nucleus of V nerve. 
 
Rhombencephalon 
In the rhombencephalon, NGF mRNA was expressed in some Purkinje cells of 
the valvula and of the body (Fig 12c,d) of cerebellum. In the latter, at the upper 
portion radial glial cells (Fig 12c) showed an intense labeling. Additionally, an 
intense labeling was observed in the cells of granular eminentiae. In medulla 
oblongata, positive cells organized in a row were observed below the glial cells 
bordering the dorsal margin of the rhombencephalic ventricle (Fig 12e, f). The 
neurons of anterior (Fig 12f), medial and posterior reticular formation  resulted 
clearly labeled. The expression of NGF was localized also in the fibers of 
gustatory tract, and in few neurons of the sensory portions of the nucleus of VII 
nerve (Fig 12e,f) and in few neurons of the octavolateral area, where the labeling 
was weakly.   
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Table 6* 
NGF ISH 
TELENCEPHALON 
 
olphactory bulbs 
internal cell layer + 
glomerular layer + 
olphactory tract +/- 
 
dorsal telencephalon 
dorso-dorsal + 
dorso-lateral ++ 
dorso-medial + 
dorso-central ++ 
ventral telencephalon ventro-lateral + 
  
ventro-ventral + 
taenia nucleus  + 
DIENCEPHALON 
preoptic area preoptic nuclei ++ 
epithalamus habenular nuclei + 
thalamus entopeduncular nucleus + 
anterior thalamic nucleus + 
ventral thalamic nucleus ++ 
hypothalamus diffuse inferior lobe ++ 
pretectum area cortical nucleus ++ 
MESENCEPHALON 
 
optic tectum 
PGZ ++ 
CZ + 
SWGZ + 
 
 
tegmentum 
glomerular nucleus ++ 
dorsal tegmental nucleus + 
semicircular tori + 
longitudinal lateral and 
medial fascicles 
+ 
nucleus of V + 
RHOMBENCEPHALON 
 
 
 
cerebellum 
valvula + 
body + 
granular eminentiae + 
reticular formation 
(anterior, medial, posterior) 
++ 
gustatory tract + 
nucleus of octavolateral area +/- 
ventricle  ++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
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Fig 11. Expression of NGF mRNA in the CNS. Transverse forebrain sections. a-b. mRNA 
NGF expressed in diffuse neurons of the dorso-central (DcT) telencephalic area (arrows) at low 
(a) and high (b) magnification. c. NGF mRNA expressed in labeled neurons of the taenia nucleus 
(NT) (arrowheads). d. NGF mRNA expressed in neurons of the anterior (ATN) (arrowheads) and 
ventral thalamic nucleus (VTN) (arrows). e. NGF mRNA expressed in cells along the margin of 
the diffuse nucleus of inferior hypothalamus (DIL) (arrowheads) and in neurons and their 
processes of the diffuse nucleus of inferior hypothalamus (DIL) (arrows). f. NGF mRNA 
expressed in neurons and their processes of the diffuse nucleus of inferior hypothalamus (DIL) 
(arrows). Scale bars: a-e = 200 µm; b-c = 100 µm; d-f = 50 µm. 
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Fig 12. Expression of NGF mRNA in the CNS. Transverse midbrain (a-b) and hindbrain 
(c-f) sections. a. mRNA NGF expressed in the cells of the periventricular grey zone (PGZ) 
(arrowheads), in few neurons of central zone CZ) (arrowheads) and superficial white and grey 
zone (SWGZ) (arrowheads) of OT. b. NGF mRNA expressed in neurons of the semicircular tori 
(TS) (arrows) and in the dorsal tegmental nucleus (Td) (arrowheads). c. mRNA NGF expressed 
in Purkinje cells (arrowheads) of the body of cerebellum and in radial glial cells (arrows) at the 
upper portion of the body. d. High magnification of NGF mRNA expressed in Purkinje cells 
(arrowheads) of the body of cerebellum. e,f. NGF mRNA expressed in glial cells (arrows) 
bordering the dorsal margin of the rhomboencephalic ventricle (rv), in neurons of the VII cranial 
nerve, motor branch (asterisk), and in neurons of the anterior reticular formation (RFa) 
(arrowheads) at low (e) and high (f) magnification. Scale bars: a-d-f = 100 µm; b-c-e = 20 µm. 
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4.3.2 IHC (Table 7) 
Telencephalon 
NGF IR was appreciated in few positive small and round cells dispersed in the 
external cell layer of the olphactory bulbs. Very few neurons and fibers were 
positive in the glomerular layer. Additionally, immunopositive fibers of the 
olphactory nerve  were detected. 
In the telencephalic hemispheres, NGF protein distribution was seen in round or 
oval shaped neurons, often showing a thin short process, of the dorso-lateral, 
dorso-central and dorso-medial areas (Fig 13a). Small neurons of the ventro-
lateral and ventro-ventral areas of telencephalon were weakly stained and rather 
numerous. In the ventro-posterior telencephalon, grouped neurons were clearly 
immunopositive to NGF (Fig 13a,b). Along the ventricle, sparse small cells, 
morphologically identifiable as glial cells, were frequently detected (Fig 13a,b). 
 
Diencephalon 
In the most rostral part of diencephalon, neurons of the entopeduncolar nucleus 
were moderately immunostained.  In the epithalamus, small positive cells of the 
habenular nuclei resulted positive. In the thalamus, NGF IR was observed in 
neurons of the ventral thalamic nucleus. In the hypothalamus, some ovoidal 
positive neurons were localized in the diffuse nucleus of the inferior lobe. Glial 
cells with their processes were stained along the diencephalic ventricle. Most 
posteriorly, neurons belonging to the pretectal nucleus and respective processes 
were immunopositive. 
 
Mesencephalon 
In the glomerular nucleus, some NGF positive neurons were distributed along 
the ventral boundary (Fig 13c,d). Few neurons of the medial longitudinal 
fascicle nucleus were also immunostained. 
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Rhombencephalon 
In the body of cerebellum numerous Purkinje cells resulted NGF 
immunoreactive (Fig 13e,f). In the medulla oblongata, many neurons intensely 
stained were localized in neurons of medial and posterior reticular formation 
and, moreover, in the nucleus of VIII nerve.   
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Table 7* 
NGF IHC 
TELENCEPHALON 
 
olphactory bulbs 
external cell layer +/- 
glomerular layer +/- 
olphactory nerve + 
 
dorsal telencephalon 
dorso- lateral ++ 
dorso- medial + 
dorso-central ++ 
 
ventral telencephalon 
ventro-lateral + 
ventro-ventral + 
ventricle  + 
DIENCEPHALON 
entopeduncolar nucleus  + 
epithalamus habenular nuclei + 
thalamus ventral thalamic nucleus ++ 
hypothalamus diffuse nucleus of inferior 
lobe 
++ 
pretectum area pretectal nucleus ++ 
ventricle  + 
MESENCEPHALON 
 
tegmentum 
glomerular nucleus ++ 
nucleus of longitudinal 
medial fascicle 
+ 
RHOMBENCEPHALON 
cerebellum body + 
 
medulla oblongata 
reticular formation 
(medial, posterior) 
++ 
nucleus of VIII ++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
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Fig 13. Distribution of NGF antigen in the CNS. Transverse forebrain (a-b), midbrain (c-
d), hindbrain (e-f) sections. a,b. NGF protein distributed in a group of neurons in the posterior 
dorsal telencephalon (DpT) (arrowheads), and in glial cells along the ventricle (arrows) at low 
(a) and high (b) magnification. c,d. NGF protein distributed in neurons along the ventral 
boundary (arrows) of the glomerular nucleus (NG) at low (c) and high (d) magnification. e,f. 
NGF protein distributed in Purkinje cells (arrowheads) of the body of cerebellum (CC) at low (e) 
and high (f) magnification. Scale bars: a-c-e = 100 µm; b-d = 25 µm; f = 10 µm. 
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4.4 NT-3 
 
4.4.1 ISH 
Any neurons or cellular populations expressed NT-3 mRNA. 
 
4.4.2 IHC (Table 8)  
NT-3 protein distribution was observed only in few cellular elements of the 
diencephalic region. Particularly, in the caudal hypothalamus single pear-shaped 
neurons sending cytoplasmic prolongaments toward the inner regions were 
observed. Along the diencephalic ventricle only few ependimocytes resulted 
positive to NT-3.  
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Table 8* 
NT-3 IHC 
DIENCEPHALON 
hypothalamus caudal hypothalamus + 
ventricle  + 
*  +++ strong; ++ mild; + weak; +/- very weak 
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4.5 NT-4 
 
4.5.1 ISH (Table 9) 
Telencephalon 
In the olphactory bulbs, few and sparse positive cells localized in the internal 
cell layers were weakly stained (Fig 14a), whereas either in medial and lateral 
olphactory tract, the fibers labeling was intense (Fig 14a). The telencephalon 
showed a strong staining, mainly evident in the neurons of the dorsal areas, 
specifically in the dorso-lateral, dorso-medial and dorso-dorsal (Fig 14b) areas. 
In the dorso-central area, a group of neurons resulted clearly labeled, whereas 
less intense staining was observed in the ventral telencephalic areas. In the 
posterior telencephalon, along the ventricle a group of cells, morphologically 
identifiable as glial cells, showed intense labeling (Fig 14c). In the most 
posterior regions of the telencephalon, some NT-4 mRNA neurons belonging to 
the taenia nucleus were labeled.  
 
Diencephalon 
A strong probe signal was observed in few neurons of the preoptic nucleus, 
stronger in parvocellular than in magnocellular portion and in the processes of 
lateral forebrain bundle. Few, well labeled neurons were observed in the anterior 
and ventral thalamic nuclei (Fig 14d). In the pretectal area, neurons of the central 
nucleus expressed NT-4 mRNA (Fig 14e). In the optic nerve some positive glial 
cells were detected. 
 
Mesencephalon 
The NT4 mRNA labeling was detected in the OT, mainly in numerous positive 
neuronal elements of the PGZ, in few dispersed neurons of the CZ (Fig 14f)  
with processes projecting toward the marginal layer and also in numerous large 
neurons of the SWGZ (Fig 14f). In the longitudinal tori labeled neurons were 
observed. Intensely labeling was detected in large neurons of the nucleus V 
nerve. 
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Rhombencephalon 
NT-4 mRNA presence was observed in some Purkinje cells localized in the 
cerebellum body (Fig 14g) and in some neurons of the caudal cerebellar lobe. 
Some positive neurons belonging to the granular eminentiae expressed NT-4 
mRNA. Intense labeling was observed in the line bordering the margin between 
the cerebellum body and the most posterior part of optic tectum (Fig 14h). The 
labeling for NT-4 mRNA was rather diffuse in the neurons belonging to the 
nucleus of octavolateral area. 
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Table 9* 
NT-4 ISH  
TELENCEPHALON 
olphactory bulbs internal cell layer +/- 
olphactory tract ++ 
 
dorsal telencephalon 
dorso-dorsal +++ 
dorso-lateral ++ 
dorso-medial + 
dorso-central + 
ventral telencephalon ventro-lateral +/- 
ventro-ventral +/- 
taenia nucleus  + 
DIENCEPHALON 
preoptic area preoptic nuclei ++ 
 
thalamus 
lateral forebrain bundle + 
anterior thalamic nucleus +/- 
ventral thalamic nucleus + 
cortical nucleus + 
optic nerve  + 
MESENCEPHALON 
 
optic tectum 
PGZ ++ 
CZ +/- 
SWGZ ++ 
longitudinal tori  + 
tegmentum nucleus of V ++ 
RHOMBENCEPHALON 
 
cerebellum 
body + 
caudal lobe + 
granular eminentiae + 
medulla oblongata nucleus of octavolateral area ++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
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Fig 14. Expression of NT-4 mRNA in the CNS. Transverse forebrain (a-e), midbrain (f) and 
hindbrain (g-h) sections. a. NT-4 mRNA expressed in the cells of internal cell layers (icl) 
(arrows) of olphactory bulbs and in fibers (arrowheads) of the olphactory tract (ot). b. NT-4 
mRNA expressed in neurons of the dorso-dorsal area (arrows) of telencephalon (DdT). c. NT-4 
mRNA expressed in the glial cells (arrowheads) along the telencephalic ventricle (tel ventr) in 
the posterior telencephalon. d. NT-4 mRNA expressed in few neurons of the anterior thalamic 
nucleus (ATN) (arrowheads) and ventral thalamic nucleus (VTN) (arrows). e. NT-4 mRNA 
expressed in neurons of the central nucleus (NC) (arrowheads). f. NT-4 mRNA expressed in 
dispersed neurons with processes of the central zone (CZ) (arrows), and also in numerous large 
neurons of the superficial white and grey zone (SWGZ) (arrows) of the optic tectum (OT). g. 
NT-4 mRNA expressed in Purkinje cells (arrowheads) of the body of cerebellum. h. NT-4 
mRNA expressed in cells (arrows) of the line between the cerebellum body and the most 
posterior part of optic tectum (OT). Scale bars: a = 200 µm; b-d-e = 50 µm; c-f-h = 100 µm; g = 
30 µm. 
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4.5.2 IHC (Table 10) 
Telencephalon 
In the olphactory bulbs, IR to NT-4 was observed in few cells of the inner cell 
layer and in many cells of the glomerular layer (Fig 15a,b).  
The distribution pattern of NT-4 in the telencephalic hemispheres was 
characterized by numerous and intensely stained neurons and fibers in the dorso-
lateral (Fig 15b,c) areas. In the dorsal area of posterior telencephalon, the 
staining was detected in relatively large neurons. 
  
Diencephalon 
In the most anterior diencephalic region, NT-4 IR was present in the neurons and 
fibers of the entopeduncolar nucleus. In the thalamus, particularly in the preoptic 
area, immunopositivity was seen in many fibers and scarce neurons of the 
suprachiasmatic nucleus and immunoreactive neurons were detected in the 
preoptic nuclei, either in magno- and parvo-cellular portions.  
In the ventral part of thalamus, numerous and strongly stained neurons were seen 
in the anterior tuberal nucleus. Still in the thalamus, fibers of the lateral forebrain 
fascicle and fibers of the ventral and dorsal optic tract were strongly 
immunoreactive to NT-4. In the hypothalamus, positive neurons and fibers were 
observed in the dorsal hypothalamus, whereas in other hypothalamic regions 
only positive neuronal populations were detected. Particularly, intense positive 
staining was seen in the neurons of the nucleus of lateral torus, in the nucleus of 
posterior recess and in the diffuse nucleus of inferior lobe of hypothalamus (Fig 
15e). Moreover, neurons of the pretectal nucleus were immunopositive. In the 
optic nerve, few cells and many fibers showed intense staining. Along the 
ventricle, some small and round neurons resulted immunopositive. 
 
Mesencephalon 
NT-4 immunoreactivity was mainly localized in the OT, where numerous 
positive fibers were observed in layers of the CZ and in layers of the SWGZ. 
Immunopositivity was seen in scarce fibers of the longitudinal tori. In the 
mesencephalic tegmentum, many fibers and neurons of the preglomerular 
nucleus, resulted NT-4 immunoreactive. The glomerular nucleus (Fig 15d) 
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showed immunopositivity in frequent neurons distributed along the border of 
nucleus and in the fibers localized in the most central part. Also, in the 
horizontal commissure some neurons and fibers were seen positive. In the 
nucleus of the medial and lateral (Fig 15e,f) longitudinal fascicles many neurons 
were detected. More posterior, strong NT-4 positivity was seen in the neurons 
and fibers belonging to the semicircular tori and in neurons of the dorsal 
tegmental nucleus.  
 
Rhombencephalon 
The pattern of NT-4 protein distribution throughout the rhombencephalic region 
was characterized by few positive Purkinje cells in the valvula and in the body 
of cerebellum (Fig 15g). In the medulla oblongata, IR was detected in scattered 
neurons of the nucleus of solitary fascicle. Intensely positive neurons and fibers 
were distributed in the nucleus of octavolateral area and strong 
immunopositivity was detected in the fibers of the VIII nerve.  
Finally, neurons of the anterior and intermedial reticular formation (Fig 15h) 
showed intense NT-4 immunoreactivity. 
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Table 10* 
NT-4 IHC  
TELENCEPHALON 
olphactory bulbs inner cell layer +/- 
glomerular layer ++ 
dorsal telencephalon dorso-lateral + 
dorso-posterior + 
DIENCEPHALON 
entopeduncolar  
nucleus 
 + 
preoptic area suprachiasmatic nucleus + 
preoptic nucleus + 
 
 
 
thalamus 
anterior tuberal nucleus ++ 
lateral forebrain fascicle ++ 
dorsal and ventral optic tract ++ 
dorsal hypothalamus ++ 
nucleus of lateral torus +++ 
nucleus of posterior recess ++ 
diffuse inferior lobe ++ 
pretectum area pretectal nucleus ++ 
optic nerve  + 
ventricle  + 
MESENCEPHALON 
optic tectum CZ ++ 
SWGZ ++ 
longitudinal tori  +/- 
 
 
 
tegmentum 
preglomerular nucleus ++ 
glomerular nucleus ++ 
horizontal commissure + 
nucleus of longitudinal 
fascicle 
++ 
semicircular tori ++ 
dorsal tegmental nucleus ++ 
RHOMBENCEPHALON 
cerebellum valvula +/- 
body +/- 
 
 
medulla oblongata 
nucleus of solitary fascicle ++ 
nucleus of octavolateral area + 
nucleus of VIII ++ 
reticular formation 
(anterior, medial) 
++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
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Fig 15. Distribution of NT-4 antigen in the CNS. Transverse forebrain (a-c), midbrain (d-f) 
and hindbrain (e-h) sections. a.  NT-4 protein distributed in few cells of the inner cell layer 
(icl) (arrows) and in many cells of the glomerular layer (gl) (arrowheads) of the olphactory bulbs 
(OB). b. NT-4 protein distributed in neurons and fibers of the dorso-lateral telencephalon (DlT) 
(arrows). c. High magnification of NT-4 protein distributed in neurons and fibers of the dorso-
lateral  telencephalon (DlT) (arrows). d. NT-4 protein distributed in neurons along the border 
(arrowheads) of glomerular nucleus (NG). e. NT-4 protein distributed in neurons of the diffuse 
nucleus of inferior lobe (arrows) of hypothalamus (DIL) and in neurons of the nucleus of the 
medial longitudinal fascicle (NFlm) (arrowheads). f. NT-4 protein distributed in neurons of the 
nucleus of the longitudinal fascicle (NFlm) (arrowheads). g. NT-4 protein distributed in Purkinje 
cells (arrows) of the body of cerebellum. h. NT-4 protein distributed in neurons of the anterior 
(RFa) (arrows) and intermedial reticular formation (RFi) (arrowheads). Scale bars: a-d-f = 25 
µm; b = 100 µm; c-d-f-g-h = 50 µm. 
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4.6 NT-6 
 
4.6.1 ISH (Table 11) 
Telencephalon 
In the olphactory bulbs, numerous labeled cells were seen in the glomerular and 
external cell layers (Fig 16a). 
In the telencephalic lobes, the expression pattern of NT-6 mRNA was 
characterized by labeling in the dorsal telencephalon: intense in the dorso-dorsal  
and dorso-central areas (Fig 16b) and moderate labeling in the dorso-lateral and 
dorso-medial (Fig 16b) areas. Also in the ventro-lateral area of the ventral 
telencephalon NT-6 expression was detected. In the dorsal area of posterior 
telencephalon, a group of neurons was intensely stained. 
Cells lining the ventricle, mainly of the central and ventral areas, were 
moderately labeled. 
 
Diencephalon 
NT-6 mRNA expression was intensely detected in the nuclei of preoptic area, 
either parvo- and magnocellular portion. 
In the epithalamus, weak labeling was detected in the small packed cells in the 
ventral part of habenular nuclei. In the thalamus, intense staining was observed 
in the anterior thalamic nucleus and in the ventral thalamic nucleus (Fig 16c). 
Moreover, positive glial  cells lining the ventricle were positive (Fig 16c). 
Caudally and in proximity of the ventricle, in the dorsal hypothalamus moderate 
labeling in some large neuron was seen. In the diffuse nucleus of inferior lobe of 
hypothalamus, a peculiar expression pattern was observed: positive cells lining 
the margin and neurons in the central portion of the lobe expressed intense NT-6 
mRNA (Fig 17c). Posterior, in the diencephalon, strong labeling was observed in 
the neurons of central nucleus (Fig 16d).   
In the optic nerve, grouped cells showed intense staining.  
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Mesencephalon 
In the OT, lower signal was detected in the PGZ (Fig 16e) and intense probe 
signal was seen in the outer layer of the SWGZ (Fig 16e). Few fibers and 
neurons were dispersed in the other layers. In the longitudinal tori, intensely NT-
6 mRNA labeled fibers were seen in the most apical part, at the margin with the 
OT, and numerous positive cells were detected mainly  in the most ventral part 
(Fig 16f). In the most caudal part of OT, the cells lining the margin between the 
OT and tegmentum were intensely labeled (Fig 17a). 
In the tegmentum, moderate labeling was seen in neurons bordering the margins 
of the glomerular nucleus, whereas intense staining was observed in the neurons 
of the horizontal commissure (Fig 17b), which project toward the ventricle. 
More medially, a positive probe signal was detected in the cytoplasm of some 
neurons of the nucleus of medial longitudinal fascicle. Densely packed cells, 
concentrically arranged, were moderately labeled in the semicircular tori. 
NT-6 expression was observed in the nucleus of trigeminal nerve. Posteriorly, 
moderate labeling was seen in the fibers of the tecto-cerebellar tract and in the 
lateral nucleus of valvula.  
 
Rhombencephalon 
In cerebellum, NT-6 mRNA was mainly localized in Purkinje cells of the 
valvula  and of the body (Fig 17c). The labeling was seen also in the upper part 
of the cerebellum, in cytoplasmatic processes of radial glial cells (Fig 17c). Few 
positive cellular elements were labeled in the cerebellar crista. 
In medulla oblongata, the expression pattern was characterized by staining in the 
neurons of octavolateral area, and in neurons of the anterior (Fig 17c,d) and 
intermedial (Fig 17c) reticular formation  .  
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NT-6  ISH 
TELENCEPHALON 
olphactory bulbs 
glomerular layer ++ 
external cell layer ++ 
 
dorsal telencephalon 
 
dorso-dorsal +++ 
dorso-lateral + 
dorso-medial + 
dorso-central +++ 
dorso-posterior + 
ventral 
telencephalon  
ventro-ventral + 
ventricle  + 
DIENCEPHALON 
preoptic area preoptic nucleus ++ 
epithalamus habenular nuclei +/- 
thalamus 
anterior thalamic nucleus ++ 
ventral thalamic nucleus ++ 
hypothalamus 
dorsal hypothalamus + 
diffuse inferior lobe ++ 
pretectum area cortical nucleus ++ 
optic nerve  + 
ventricle  ++ 
MESENCEPHALON 
optic tectum 
PGZ ++ 
SWGZ + 
longitudinal tori  + 
tegmentum 
glomerular nucleus + 
horizontal commissure ++ 
nucleus of medial 
longitudinal fascicle 
+/- 
semicircular tori + 
nucleus of V ++ 
tecto-cerebellar tract + 
lateral nucleus of valvula + 
RHOMBENCEPHALON 
 
cerebellum 
valvula ++ 
body ++ 
cerebellar crista +/- 
 
medulla oblongata 
nucleus of octavolateral area + 
reticular formation 
(anterior, medial) 
++ 
*  +++ strong; ++ mild; + weak; +/- very weak 
Table 11* 
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Fig 16.  Expression of NT-6 mRNA in the CNS. Transverse forebrain (a-d), midbrain (a-f) 
sections. a. NT-6 mRNA expressed in cells of the glomerular (gl) (arrows) and external cell 
layers (ecl) (arrowheads) of olphactory bulbs. b. NT-6 mRNA expressed in neurons of the dorso-
dorsal (DdT), dorso-medial (DmT) and dorso-central (DcT) areas of telencephalon  
(arrowheads). c. NT-6 mRNA expressed in neurons of the anterior (ATN) and the ventral 
thalamic nucleus (VTN) (arrowheads), and in glial  cells (arrows) lining the diencephalic 
ventricle (dienc ventr). d. NT-6 mRNA expressed in neurons of cortical nucleus (arrows). e. NT-
6 mRNA expressed in fibers of the outer layer of the superficial white and grey zone (SWGZ) 
(arrows) and in cells of the periventricular grey zone (PGZ) (arrowheads) of the OT. f. NT-6 
mRNA expressed in fibers of  the the most apical part of longitudinal tori (TL) (arrows), at the 
margin with the optic tectum (OT) (arrows), and in cells of the most ventral part of TL 
(arrowheads). Scale bars: a-b-e = 200 µm; c-d-f = 100 µm. 
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Fig 17. Expression of NT-6 mRNA in the CNS. Transverse midbrain (a-b), hindbrain (c-d) 
sections. a. NT-6 mRNA expressed in the cells lining the margin between the optic tectum (OT) 
and tegmentum (Teg) (arrows). b. NT-6 mRNA expressed in the neurons of the horizontal 
commissure (CH) (arrowheads). c. NT-6 mRNA expressed in Purkinje cells (arrowheads) and in 
radial glial cells (arrowheads) at the uppermost part of cerebellum, in neurons of the anterior 
(RFa) and intermedial (RFi) reticular formation (arrowheads), in cells along the margin and in 
the central part of the diffuse nucleus of inferior lobe (DIL). d. High magnification of neurons of 
anterior reticular formation (RFa) (arrows) expressing NT-6 mRNA. Scale bars: a-b = 100 µm; c 
= 400 µm; d = 50 µm. 
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4.7 Phylogenetic analysis 
 
The built phylogenetic tree  is shown in Fig 18.  
The tree obtained yielded a congruent phylogeny for both nucleotide and 
aminoacid sequences of BDNF. This gene tree fits the “species” tree expected on 
the basis of the accepted species relationships, indicating that the genes sampled 
are indeed orthologous, and therefore suited for subsequent analyses on 
substitution rates.  
With the regards to the construction of the tree of all other neurotrophins, the 
tree substantially agree with those previously reported: it highlights that the four 
vertebrate neurotrophins were generated by two subsequent duplication events of 
an ancestral gene, one involving the generation of the NGF/NT-3 and another 
involving generation of BDNF/NT-4/5 groups after the split of lamprey from the 
common vertebrate lineage (Hallböök et al., 1999, 2001; Lanave et al., 2007).  
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Fig 18. The phylogenetic tree of  nucleotide and aminoacid BDNF sequences was reconstructed 
by MEGA5. For N. furzeri, the nucleotide sequence is listed in 3.4.5. 
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5. DISCUSSION 
 
The current study describes an atlas of the brain of N. furzeri in the transverse 
plane. The brain atlas is also useful for comparative studies, and is propaedeutic 
for neuroanatomic investigations.  
This survey reports, for the first time, the presence and distribution of 
neurotrophins in the brain of N. furzeri, a teleost which is a new aging model. In 
addition, it is also the first microscopical localization of NT-6 in teleosts and the 
first description of NGF and NT-4 in teleost brain. Except for NT-3, which is 
practically lacking, all neurotrophins were widely diffused throughout the 
different regions of the brain, preferentially localized in neurons and other 
cellular populations, such as glial cells lining the ventricles or immature cells 
(neuroblasts/glioblasts) of supposed neurogenic areas.  
 
5.1 Methodological approaches:  
in situ hybridization technique and 
immunohistochemistry 
Two methodological approches were used to investigate neurotrophin 
distribution: ISH and IHC techniques. 
ISH is a commonly used sensitive technique to identify, localize, and study 
regulation of mRNA expression in brain tissue sections.  
To detected BDNF mRNA distribution, two different types of probes for the ISH 
experiments were employed: locked nucleic acid (LNA) and DNA 
oligonucleotides probes. The LNA is an engineered nucleic acid analogue, 
containing one or more LNA nucleotide monomers with a bicyclic furanose unit 
locked in an RNA-mimicking sugar conformation (Petersen and Wengel, 2003; 
Shantanu and Deepak, 2006). The hybridization properties of LNA 
oligonucleotides have been evaluated in several different sequences, ranging 
from six to 20-nucleotide long oligomers with various levels of LNA content 
(Wahlestedt et al., 2000).  Oligonucleotides containing LNA exhibit thermal 
stabilities toward complementary DNA (Wengel, 1998) and RNA and toward 
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complementary DNA and RNA and exhibit excellent mismatch discrimination. 
Moreover, LNA probes enhance hybridization efficiency, (Kubota et al., 2006), 
hybridization specificity and duplex stability (Mctigue et al., 2004). LNA probes 
can also alternatively detect spliced exons (Darnell et al., 2010). Despite these 
attributes, the use of LNAs to detect mRNAs is up to date very limited. Darnell 
et al. (2010) investigated the use of LNA containing DNA probes for whole 
mount ISH detection of mRNAs. However, the use of LNA probes to study 
mRNAs expression on tissue sections has not been reported. To evaluate the 
feasibility of using short LNA containing oligonucleotides as hybridization 
probes for detection of mRNAs by sections, ISH LNA probes were designed and 
were tested in parallel with the DNA oligonucleotide probes. Hence, a 
comparison between the two probes was carried out to confirm the expression of 
the BDNF mRNA and to further validate the employment of the LNA probes for 
detecting mRNAs coding for structural, signaling, and transcriptional regulatory 
proteins. Both the probes revealed an analogous expression pattern throughout 
the CNS, by labeling the same encephalic nuclei.  The ability of short LNA 
probes to detect mRNA sequences allows for the localization of specific splice 
variants and allows probes to be designed in silico and chemically synthesized, 
eliminating the need for a cDNA template. 
Thus, for the detection of NGF, NT-3, NT-4 and NT-6 mRNAs, only LNA 
probes were employed. 
Regarding IHC, for this study commercially available antibodies against NGF, 
BDNF, NT-3 and NT-4 were employed. In pairwise alignments, the amino acid 
sequence for N. furzeri BDNF displayed about 86–97% identity with BDNF 
sequences from other teleost fish, Xenopus, chicken, rat, pig and human. 
Concerning NGF, NT-3, NT-4, the overall identity of aminoacid sequences in 
pairwise alignments show reduced percentage. Particularly, NGF, NT-3 and NT-
4 share an aminoacid sequence identity of about 60% between mammals and 
teleosts. However, the antisera employed were directed against well conserved 
sequences. 
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5.2 BDNF 
 
5.2.1 Comparative analysis of BDNF localization in N. furzeri brain  and 
other vertebrate species 
Studies on neurotrophins in teleosts are focused mainly on the occurrence of 
BDNF and its receptor TrkB over different tissues, ranging from developmental 
to adult stages (Hashimoto and Heinrich, 1997; de Girolamo et al., 1999, 2000; 
Lucini et al., 1999, 2001, 2002; Hannestad et al., 2000; Catania et al., 2007; 
Germanà et al., 2004, 2010a, 2010b;). In teleost CNS, data on the presence of 
BDNF were reported in the neuroanatomical description of the expression of 
mRNA BDNF throughout the brain of adult Anguilla anguilla (Dalton et al., 
2009), and the expression of BDNF and its receptor TrkB after spinal cord injury 
in Anguilla anguilla (Dalton et al., 2009). Additionally, BDNF 
immunoreactivity-like was reported in the brain and retina of Cichlasoma 
dimerus (Vissio et al., 2008). 
Coherently with the results reported in the teleost species (Dalton et al., 2009; 
Vissio et al., 2008), the occurrence of  mRNA BDNF expression and BDNF 
protein was detected in all region of the brain of N. furzeri. Comparing the 
occurrence of BDNF in N. furzeri brain to the pattern of expression of BDNF in 
A. anguilla brain, a cospicuous number of corresponding nuclei and zones 
showed BDNF expression in both N. furzeri and A. anguilla.  
In the telencephalon of A. anguilla, both in olphactory bulbs and telencephalic 
hemispheres, rostral and caudal parts, the BDNF mRNA expression was widely 
described in all regions of telencephalon and olphactory bulbs. Few scattered 
cells were lightly labeled in the entopeduncolar nucleus of A. anguilla (Dalton et 
al., 2009). Interestingly, the neurons of the entopeduncolar nucleus of N. furzeri 
brain were positive to BDNF protein, whereas the BDNF mRNA was not 
detected. Some dissimilarities of the BDNF mRNAs expression, between N. 
furzeri and A. anguilla, were observed in the diencephalon. In A. anguilla, 
BDNF mRNA was detected in the periventricular zone of hypothalamus, caudal 
and ventral, in the subcommissural and posteriorly paraventricolar organ, and in 
preglomerular complex. In N. furzeri, there was nor BDNF mRNA or protein, 
detectable in those brain structures.  The overall pattern  of BDNF mRNA 
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expression in mesencephalon and rhomboencephalon did not reveal significant 
differences between A. anguilla and N. furzeri. The most relevant difference is 
attributable to the detectability of BDNF in the lateral nucleus of cerebellar 
valvula and Mauthner-like cell of A. anguilla, while no positive BDNF products 
were found in the analogous structures of N. furzeri CNS. The different sites of 
distribution could be related to different experimental procedures, but also to 
species specific characteristics, bearing in mind that N. furzeri and A. anguilla 
are two species philogenetically distant to each other.  
The expression pattern detected in N. furzeri brain seems to be consistent also 
with the data available on the expression of mRNA BDNF in mammals (Conner 
et al., 1997), avian (Herzog and von Batheld, 1998) and amphibian brain 
(Duprey-Diaz et al., 2002), taking into account the neuroanatomical differences 
and homologies relative to the species. Particularly, homologies between 
mammals and teleosts brain have been widely discussed. Several hypothesis 
have been formulated on the equivalent of teleostean telencephalon. However, 
the common starting point was the well accepted idea that the teleostean 
telencephalon, during the development, undergoes a eversion process instead of 
an evagination, as occurs in mammals. Consequently, the dorsal telencephalic 
areas correspond to the mammalian pallial formation and the ventral one to the 
subpallium. Specifically, Wullimann and Mueller (2004) found that the 
teleostean dorso-lateral telencephalon would be the mammalian homologous of 
medial pallium or hippocampus; the everted part of dorso-medial telencephalon 
would correspond to the dorsal pallium of other vertebrates (isocortex 
homologue); the pallial masses ventral to dorso-lateral would not be everted. 
Furthermore, the adult posterior zone of dorsal telencephalic area would be the 
lateral pallium of other vertebrates (i.e. the olfactory cortex homologue); the 
midline portion of the medial zone of dorsal telencephalic area would 
correspond to the homologue of the pallial amygdala. The adult dorsal and 
ventral areas of the ventral telencephalon would correspond respectively to the 
striatum and septum homologues. This hypothesis support the theory of the 
partial eversion of teleostean telencephalon, contrasting the complete eversion 
theory (Nieuwenhuys, 2009). According to the latter theory, the dorso-lateral 
telencephalon is homologous to the medial pallial formation, the ventro-dorsal 
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and ventro-central to the striatal formation, and the ventro-ventral and ventro-
lateral to the septal formation.  
Bearing in mind the homologies, in rodents CNS, BDNF mRNA expression was 
detected in the amygdala, hippocampus and some other basal nuclei where 
BDNF seems involved in the functional role of the structure (Conner et al., 
1997). Thus, it is presumable that BDNF in N. furzeri brain might act and 
regulate functional activity of the telencephalic neurons. Furthermore, in rodents 
occurrence of BDNF mRNA was seen in several dopaminergic thalamic nuclei 
(Conner et al, 1997). In N. furzeri, putative dopaminergic nuclei, equivalent to 
the mammalian ones, such as the anterior and ventro-thalamic nuclei, and  the 
preoptic nuclei, resulted positive to BDNF. These nuclei, in mammals as well as 
in teleosts, represent an important sensory relay station, although the 
dopaminergic ascending system seems to have different organization: in fact, in 
teleost the ascending system origins from the rostral encephalic region, precisely 
from diencephalon (Rink and Wullimann, 2001; Rink and Wullimann, 2002), 
whereas in mammals from mesencephalic tegmentum.   
In N. furzeri, mRNA BDNF expression was observed in the dorsal and ventral 
habenular nuclei respectively considered as homologues of the mammalian 
medial and lateral habenulae (Amo et al., 2010) where Conner et al. (1997) 
detected BDNF transcript.   
Moreover, in N. furzeri, intense labeling of BDNF was seen in the semicircular 
tori, an important station of sensory inputs. Based on comparative studies, these 
symmetric structures correspond to the mammalian inferior colliculus, which 
also showed BDNF expression (Conner et al., 1997).  
More caudally, in the cerebellum of N. furzeri BDNF intense labeling was 
observed in Purkinje neurons of the valvula, body and caudal lobe, and in cells 
of the granular layer. In rat (Conner et al., 1997) as well as in human (Quartu et 
al., 2010), the BDNF expression was not reported in adult cerebellum, whereas 
it was described in the cerebellum of both human (Quartu et al., 2010) and rat 
(Rocamora et al., 1993) during postnatal development.  
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Fig 19. Complete (left) vs. incomplete (partial; right) pallial eversion model in teleosts and 
hypothetical relationship of four tetrapod (medial, dorsal, lateral, ventral) pallial zones to adult 
teleostean pallial zones. Abbreviations: MP medial pallium; DP dorsal posterior thalamic 
nucleus; LP lateral pallium; VP ventral pallium; Str striatum; Sep spetum; Dm medial zone of 
area dorsalis telencephali; Dd dorsal zone of area dorsalis telencephali; Dl lateral zone of area 
dorsalis telencephali; Dc central zone of area dorsalis telencephali; Dlv latero-ventral area 
dorsalis telencephali; Dp posterior zone of area dorsalis telencephali (Wullimann and Mueller, 
2004). 
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Strong BDNF labeling was also appreciated in the nuclei of  reticular formation 
in the CNS of  N. furzeri. The reticular formation is a descending supraspinal 
system, which modulate a range of motor behaviors that include swimming, 
startle responses, posture adaptation and walking in land vertebrates. 
Interestingly, in mammals, the teleost equivalent of reticular formation did not 
reveal BDNF occurrence.  
In N. furzeri as well as in the eel, intense BDNF labeling was detected in brain 
structures involved in the visual system, such as nuclei of preoptic area, 
preglomerular and glomerular nuclei, optic tectum, semicircular tori. BDNF, as 
well as other neurotrophins, influence proliferation, neurite outgrowth and 
survival of cells in the visual system in vitro and in vivo (for a review see von 
Bartheld, 1998). Therefore, it is likely to hypothesize a functional role of BDNF 
in N. furzeri visual system as well as an involvement in terms of regeneration 
and proliferation activities. 
 
5.2.2 mRNA and protein distribution: evidence of anterograde and        
retrograde transport? 
BDNF mRNA and protein were often localized in the neuronal soma, and BDNF 
protein was particularly visualized in numerous fibers forming diffused mesh or 
running together in fascicula. The high number of fibers positive to BDNF 
protein represents clear clues for an active transport of BDNF along neuron 
terminals that, by the obtained results, could be a retrograde as well as an 
anterograde transport. Retrograde transport along the axon represent the 
traditional view of neurotrophic factor biology, but it is now largely accepted 
that trophic factors, and particularly BDNF, can move anterogradely along axons 
and be transferred to the postsynaptic target cells (for a review see Caleo and 
Cenni, 2004). Some fibers were also positive to BDNF mRNA, although less 
numerous than BDNF protein, suggesting in adult N. furzeri brain a translational 
activity which is not limited to the soma, but also occurs at dendritic levels as 
previously described in mammals. BDNF, as other molecules involved in 
synaptic plasticity, can be delivered in form of silent mRNA at synapses where it 
is further locally translated (for a review see Tongiorgi, 2008). 
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Many nuclei showed labeling to both BDNF mRNA and protein, like 
parvocellular and magnocellular, anterior thalamic, central, dorsal tegmental and 
glomerular nuclei. Although investigating the neuronal co-localization of ISH 
and IHC is beyond the purpose of this study, it is quite presumable that neurons 
belonging to the same nucleus both transcribe and translate BDNF. However, 
there are nuclei whose neurons expressed only BDNF mRNA or only the 
protein. Probably the localization of mRNA is sufficient to indicate that 
translation occurs although the protein was not detected, likely for its paucity. 
Indeed, BDNF protein seemed to be stored in N. furzeri brain at very low levels, 
because only a very sensible method such as EnVision was able to detect BDNF, 
while other methods, as PAP, ABC, failed to reveal immunoreactivities 
(unpublished data). The finding showing only BDNF protein in the nuclei could 
reflect true lack of mRNA transcription, and consequently the neurons should 
uptake BDNF in intersynaptic space by means of retrograde transport along the 
axon toward the soma. Furthermore, among these nuclei, ventromedial thalamic 
nucleus, paraventricular organ and solitary fascicle nucleus are very close to 
ventricles and could act as cerebrospinal fluid (CSF) contacting neurons. These 
latter send dendritic processes into the internal CSF and take up substances from 
the brain ventricles and, then, transmit them through perikarya to synaptic zones 
of various brain areas. Besides, in fish CSF contacting neurons were reported to 
be more numerous than in mammals (Vigh et al., 2004). Because in mammals 
CSF contains BDNF and its level is related to neurological diseases (Papaliagkas 
et al., 2010; Kizawa-Ueda et al., 2011), it could be intriguing to retain that 
neurons of these nuclei take up BDNF from CSF and then release it by axonal 
anterograde transport.  
 
5.2.3 BDNF: possible implications in neurogenesis and neuroregeneration 
processes 
The cellular proliferation is particularly pronounced in the dorsal telencephalon, 
preoptic area of the diencephalon, longitudinal tori, optic tectum and in all 
cerebellar subdivisions of some fish, such as brown ghost (Zupanc and 
Horschke, 1995), gilt head sea bream (Zikopoulos et al., 2000), goldfish (Meyer, 
1978; Raymond and Easter, 1983), guppy (Kranz and Richter, 1970), stickleback 
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(Ekström and Ohlin, 1995), and zebrafish (Zupanc et al., 2005). Preliminary 
studies in N. furzeri CNS also seem to suggest a similar pattern of distribution of 
mitotic cells (unpublished data). The obtained results on distribution of BDNF in 
N. furzeri appeared often present in areas of neurogenesis. In particular,  all 
nuclei of the preoptic area are reported to show mitogenic cells, and both 
magnocellular and parvocellular preoptic nuclei displayed BDNF. In the optic 
tectum, mitogenic areas are identified mainly in the periventricular grey zone 
and superficial layers, where BDNF mRNA and protein were particularly dense. 
 In the cerebellum body, BDNF was present in the molecular layer and limited to 
a medial zone of the granular layer. Zupanc et al. (2005) described proliferation 
zones in the cerebellum body, restricted to areas at and near the midline in the 
dorsal and ventral molecular layers. The new cells migrate from the sites of 
origin to specific target areas (Zupanc et al., 1996) which are the granule cell 
layers in both the cerebellum body and the valvula, lateral and medial parts. 
Taking in account that BDNF has been identified as a molecule that contribute to 
stimulate rodent adult neurogenesis of olfactory bulbs (subependymal zone of 
the lateral wall) and hippocampus (subgranular zone), regulating the 
proliferation, migration and survival of newly born neurons (for a review see  
Bath and Lee 2010; Bath et al., 2011), the present observation regarding the 
brain of N. furzeri strongly suggest an involvement of BDNF in neurogenic 
process. These results could open new perspectives for better understanding the 
biological function of adult neurogenesis in lower vertebrates models, like N. 
furzeri, for aging research in view of studying treatment of neurodegenerative 
diseases. 
 
5.3 NGF 
5.3.1 Comparative analysis of NGF localization in N. furzeri and rodents 
brain 
The widespread expression of NGF in the telencephalon of N. furzeri  recalls the 
localization of NGF in the corresponding neuroanatomical structures of 
mammalian forebrain. NGF is synthesized and secreted by cells in the cortex and 
hippocampus and acts on neurons of basal forebrain nuclei by binding TrkA and 
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p75 (Shelton and Reichardt, 1986; Conner and Varon, 1992; Conner et al., 1992; 
Talamini and Aloe, 1993; Niewiadomska et al., 2011). The neurons of 
mammalian basal forebrain nuclei are recognized as cholinergic. A recent paper 
on the cholinergic teleostean system confirms that the neurons of the ventral 
telencephalic areas (corresponding to the mammalian subpallium) are 
cholinergic (Mueller et al.,  2004).  The presence of NGF in these areas of N. 
furzeri encephalon suggests that also in teleost NGF may act as a target-derived 
trophic factor for cholinergic neurons (Talamini and Aloe, 1993). The 
cholinergic neurons of the basal forebrain nuclei have been assumed undergo 
moderate degenerative changes during aging, resulting in cholinergic 
hypofunction that has been related to the progressing memory deficits with 
aging. In pathological aging, such as Alzheimer‟s disease, the above-mentioned 
degenerative changes are more relevant. The significant cholinergic cell loss 
during aging has been challenged. In particular, the cholinergic dysfunction may 
be related to imbalances in the expression of NGF as well as to changes in 
acetylcholine release, high-affinity choline uptake, and alterations in muscarinic 
and nicotinic acetylcholine receptor expression (for a review see Schliebs and 
Arendt, 2011). Hence, the occurrence of NGF molecule in the cholinergic 
neurons in the adult CNS of N. furzeri might represent a baseline study for 
understanding the molecular mechanism of neurodegeneration diseases, such as 
Alzheimer disease.  
 
5.3.2 NGF:  spatial expression and distribution of mRNA and protein in the 
CNS 
ISH and IHC were employed to map the cellular localization of NGF mRNA and 
protein in the adult brain of N. furzeri. Not in all encephalic regions, the 
distribution of NGF mRNA overlapped with the distribution of NGF protein.  
NGF mRNA expression was rather intense in the telencephalic region, 
specifically in the dorsal and ventral areas of telencephalon. NGF protein 
showed a similar pattern of distribution but appeared less distributed in the 
ventral areas. In the diencephalon, neurons of the nuclei of the preoptic area, the 
habenular nuclei, the ventral thalamic nucleus and the diffuse nucleus of inferior 
lobe of hypothalamus were positive to both NGF mRNA and protein. Moreover, 
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the mRNA was expressed in the entopeduncolar nucleus, whereas the protein 
was present in the pretectal nucleus. Deep differences were noted in the 
mesencephalon, where the mRNA was widely appreciated, as it resulted 
expressed in all major structures of mesencephalic region such as optic tectum, 
longitudinal tori, central nucleus, glomerular nucleus, semicircular tori, 
longitudinal and medial fascicles in contrast to the protein, whose localization 
was limited to glomerular nucleus, semicircular tori, medial longitudinal 
fascicle. More caudally, in the rhombencephalon, the localization of both NGF 
mRNA and protein was seen in Purkinje cells of the cerebellum body, in the 
medial and inferior nuclei of reticular formation and in the nucleus of VIII nerve. 
The mRNA expression was detectable in the fibers of gustatory tract. However, 
in certain nuclei, NGF mRNA and protein overlapped. For example, in the 
glomerular nucleus NGF mRNA and protein were observed in neurons localized 
along the inferior external margin of nucleus, or in the cerebellum, where 
Purkinje cells positive to NGF mRNA and were also immunopositive to the 
protein. It is likely to hypothesize that those neurons act as targets-cells as well 
as storage for NGF.  
In rat brain, the detection of NGF antigen by immunohistochemical methods was 
seen in restricted neuronal populations among all synthesizing NGF (Conner and 
Varon, 1992; Conner et al., 1992). The occurrence of the protein could be due to 
the retrograde transport and accumulation of NGF from distant sites of synthesis. 
Moreover, the antigen was identified in locations other than within cell bodies 
(i.e., the hippocampal mossy fiber region), indicating that the site where a 
protein is stored need not be within the cell body, where the synthesis occurs 
(Conner et al., 1992). Therefore, accumulation of a protein at extracellular sites 
may result from either an anterograde transport down axonal or dendritic arbors 
of the producing cell, or by the selective binding or uptake and accumulation of 
protein released into the extracellular space. 
A previous study on the distribution of TrKA receptor in the CNS of N. furzeri 
(D‟Angelo et al., 2011) described TrkA IR in fibers and rare neurons distributed 
in the areas of dorsal and ventral telencephalon. Thus, the colocalization of 
mRNA, protein and receptor could indicate that NGF is synthesized by certain 
telencephalic neuronal populations and, therefore, NGF might act in an autocrine 
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manner. Given the high TrkA immunopositivity in fibers throughout the 
telencephalon and the pattern of NGF molecule expression, it is likely to confirm 
the active retrograde transport of signaling endosomes carrying NGF bound to 
activated TrkA (for a review see Campenot, 2009). The retrograde transport 
could influence the microenvironment by exerting paracrine actions on different 
neuronal populations, leading to tissue protection, repair, and regeneration.  
 
                        5.4 NT-3 
NT-3: limited protein distribution and no detectable mRNA 
The neuroanatomical distribution of NT-3, either the mRNA and protein, was 
almost absent throughout the whole CNS of N. furzeri. Particularly, the mRNA 
expression was not detectable in any regions. This may be discussed in relation 
to the technique employed. The LNA probe could have not hybridized properly, 
although the protocol followed the same steps of all other neurotrophins and, 
moreover, other experiments carried out on non neural tissues expressed the 
mRNA. In mammals, the localization of NT-3 is manifested at all developmental 
stages studied and into adulthood (for a review see Chalazonitis, 1996).  In the 
adult brain of rats, the expression of the NT-3 gene was predominantly confined 
to the hippocampal formation and cerebellum (Maisonpierre et al., 1990; 
Ceccatelli et al., 1991  Friedman et al., 1991; Lauterborn et al., 1994), and with 
a less extent in other brain regions. By contrast, the protein NT-3 was distributed 
in glia and neurons of numerous brain structures, with the most abundant 
immunopositivity in the forebrain cortex, hippocampus and cerebellum (Zhou 
and Rush, 1994). The presence of the NT-3 protein in the adult brain of N. 
furzeri was limited to some specific areas such as hypothalamic region or along 
the diencephalic ventricle. Repeated trials showed the distribution of the antigen 
in other structures, such as pituitary gland or some encephalic ganglia. The 
lower distribution of NT-3 may be attributable to a limited role in the biology of 
adult CNS of teleosts. The functional role of NT-3 in the teleosts brain deserves 
more investigations, considering also the lack of available information. In this 
sense, it is challenging to study the expression during development, so that a 
comparison in relation to the age could be helpful for better understanding the 
functional role of NT-3 in the brain of teleosts.  
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 5.5 NT-4 
NT-4: restricted spatial expression and distribution in the CNS 
NT-4 was moderately expressed in the brain of N.furzeri. Although similarities 
between NT-4 and BDNF, due to the common ancestor gene and the affinity to 
binding to the same TrkB receptor, the occurrence of NT-4 molecule in the CNS 
of N. furzeri was rather limited to few regions. The highest rate of NT-4 
products was appreciated in the telencephalon, where both mRNA and protein 
were localized. The occurrence was detectable in some nuclei involved in the 
visual pathways, such as the preoptic nucleus and the pretectal area, as well as in 
the Purkinje cells of the cerebellum, in the reticular formation and in some other 
nuclei of medulla oblongata. However, it is noteworthy that there was no equal 
correspondence between mRNA and protein in the same neuronal populations. 
Indeed, a number of nervous structure which did not express detectable NT-4 
mRNA showed IR to NT-4 antibody, which recognizes internal region of NT-4 
of fish origin. Differences in the localization of mRNA and protein were also 
observable in the results of the other neurotrophins, but in regard to NT-4 these 
differences appeared more distinct and evident. Alike in mammals (Friedman et 
al., 1998), in N. furzeri encephalon the protein distribution was observed in 
neuronal populations where no mRNA was detectable. For example, the 
longitudinal tori and the glomerular nucleus showed the presence of antigen but 
not the mRNA. It is presumable that the site of action might not be the site of 
snthesis of the factor, or that the protein was transported to the site of action. 
This observation could suggest that also in teleosts NT-4 might be involved in 
axonal retrograde and anterograde transport, and even in transcellular signalling 
(Wirth et al., 2005). In this way NT-4 supports afferent and efferent neurons in 
different target areas.  
In mammals, studies demonstrated that the amount of NT-4 in the brain, 
irrespective of the brain regions and post-natal ages, were far lower than those in 
other organs (Timmusk et al., 1993; Katoh-Semba et al., 2003). Even though the 
levels were lower in rat brain, NT-4 seems to have specific functions in the 
individual brain regions, because significant changes in the NT-4 concentration 
with post-natal development of the brain were observed in several regions. 
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Interestingly, in rat CNS, NT-4 showed changes in the concentration related to 
age. While after birth the level of NT-4 in thalamus considerably decreased 
(Katoh-Semba et al., 2003), marked increases in levels of NT-4 with post-natal 
age were observed in layer 5 and 6 of the neocortex, in the olfactory bulb, the 
hypothalamus, and the brain stem (Katoh-Semba et al., 2003). Therefore, in 
mammals NT-4 plays a role in the CNS either in development  and in adulthood. 
The occurrence of NT-4 level in the adult brain of N. furzeri indicates that the 
biological function of the neurotrophin in specific nervous structures and 
neuronal populations remains to be elucidated.      
 
5.6 NT-6 
NT-6: evidences of mRNA expression  
NT-6 expression in the brain of N.furzeri represents the first neuroanatomical 
description in teleosts. NT-6 was first identified in the teleost fish Xiphophorus 
as a new member of the neurotrophin gene family. A supposed, evolutionarily 
close neurotrophin, NT-7, was isolated and identificated in other teleost species, 
zebrafish (Nilsson et al., 1998) and carp (Lai et al., 1998). However, molecular 
studies have demonstrated that in fish only NT-6 exists (Dethleffsen et al., 
2003), and that the mature proteins of NT-6 and NT-7 genes are closely related 
to NGF, since they have evolved from a common ancestor after a single "fish 
specific" duplication of NGF (Dethleffsen et al., 2003).  
Up to date, the data on NT-6 are very limited. In this survey, only mRNA 
detectability was reported, since there are not commercially available antibodies. 
In Xiphophorus, NT-6 transcripts are described to be expressed during the 
embryonic development as well and in the adulthood. It was found in the brain, 
gill, liver and eye and with weak expression in heart, liver, skin, spleen and 
skeletal muscles (Götz et al., 1994). In the brain of N. furzeri, NT-6 resulted 
largely localized throughout different brain regions. The survey reported an 
almost ubiquitous distribution of cells expressing NT-6 mRNA within the CNS. 
Interestingly, a peculiar pattern of NT-6 mRNA expression was observed in 
certain regions. For example, in the optic tectum, where the labeling was 
specifically detected in the cells and fibers along the most superficial margin of 
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the superficial gray zone. This particular pattern might shed light on the 
involvement of NT-6 in the visual system of N. furzeri, as it has already been 
hypothesized for other neurotrophins. In mammals, indeed, all neurotrophins 
play different roles in regulating visual cortical development and plasticity by 
acting on different neural targets (for a review see Berardi and Maffei, 1999).  
Furthermore, in the brain of Xiphophorus, Götz et  al. (1994) detected transcripts 
in the embryonic valvula of cerebellum, although the cellular population was not 
identified. In the adult N. furzeri cerebellum, transcripts of NT-6 were surveyed 
in the Purkinje cells of either valvula and body, and in the processes of radial 
glial cells in the upper portion of cerebellum body. This observation is of great 
interest, since radial glia represents one of the subpopulation of progenitors in 
the adult teleostean brain (Pellegrini et al., 2007; Ganz et al., 2010; 
Rothenaigner et al., 2011; Chapouton et al., 2011) and moreover, relative large 
numbers of new cells are generated in the cerebellum of fish. It is likely to 
assume that also NT-6, among several dozens of molecular factors, potentially 
contribute to the process of neurogenesis and neuroregeneration in teleosts. 
However, very few is known about the biological and challenging role of NT-6 
in fish. Up to date, in vitro studies and phylogenetic analysis have been 
performed aiming at clarifying the biological features of this neurotrophin. In 
vitro studies reported that NT-6 promoted neuronal survival and neurite 
outgrowth (Li et al., 1997). Phylogenetic analysis of the neurotrophins,  
performed on mature aminoacid sequences (Hallböök et al., 1991, 1999) 
supports the notion that NT-6 evolved early in vertebrate history during two 
rounds of duplication events of an ancestral gene, the gene encoding for 
NGF/NT-3/NT-6. Further studies have shown that the genomic organization and 
transcript structure of NGF and NT-6 in the teleost zebrafish share a high 
similarity with the mouse NGF (Dethleffsen et al., 2003), and suggest that 
teleost NT-6 has evolved from a common ancestor after a single “fish specific” 
duplication of NGF. Moreover, like NGF, NT-6 interacts only with the receptor 
TrkA, although weakly (Götz et al., 1994; Lai et al., 1998). It is of great interest 
to deepen the role of NT-6, also in relation to NGF.  
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6. CONCLUSIONS 
 
 Model organisms have played a huge part in the history of studies of human 
genetic disease, both in identifying disease genes and characterizing their normal 
and abnormal functions. Over the model organisms, fish have lots of advantages. 
They have similar body plans and similar tissues and organs to humans, and they 
are much easier and cheaper to look after than the classical rodents models. 
Furthermore, the development and improvement of the genomic tools have 
contributed to stimulate interest in fish, and reinforce the usefulness as model 
organism in the research. In the neurobiology research, fish reflect the main idea 
that the understanding of the simplest system provides a road map for 
understanding the fundamental working units in the CNS. This idea was the 
substrate on which this research has been structured. This study has, at first, 
been focused on the neuroanatomy of the model employed. Thus, a 
comprehensive whole brain atlas of N. furzeri was constructed as baseline for 
following experimental procedures. The map of encephalon will potentiate the 
representation of structural and functional data of future experiments. 
The identification and characterization of cDNA fragment complementary to the 
mRNA sequences which encode the mature form of  neurotrophins allowed to 
study, for the first time, the gene structure and the expression patterns of each 
neurotrophin in the CNS of the teleost N. furzeri. With respect to the expression 
pattern, the innovative detection of mRNAs by LNA/DNA probes and the 
compared expression patterns between the LNA/DNA and riboprobes open new 
perspectives for the applicability of LNA probes for ISH. 
 Finally, the achieved results on the occurrence of neurotrophins in the brain of 
N. furzeri have added new information regarding neurotrophin biology in 
vertebrates, and in teleost fish particularly. The main points of interest emerging 
from this research are that neurotrophins, except NT-3, are all widely expressed 
in N. furzeri brain, and are localized in numerous nuclei and in active 
proliferating areas. Moreover, the comparison between the distribution of 
mRNAs and proteins has suggested hypothesis concerning the identification of 
122 
 
neurotrophin synthesis and storage areas, and assumptions regarding their 
retrograde/anterograde transport.  
In conclusion, neurotrophins appear involved in many biological functions of the 
adult brain of  N. furzeri.  
The comprehension of the role of these molecules in the brain of N. furzeri is a 
formidable tools to investigate the etiology, the course and the potential 
treatment of neurodegenerative diseases. Neurotrophins, indeed, are markedly 
involved in Alzheimer disease, Parkinsons‟ disease, Hungtinton diseas, ALS, 
mood disorder, thus it appears extremely advantageous the study of 
neurotrophins in the N. furzeri model system. 
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7. ABSTRACT 
 
In biomedical and veterinary research, fish represent an extraordinary repertoire 
of models with which to carry out experiments. In the basic neuroscience, fish 
offer examples that indicate the usefulness of comparative neurobiological 
investigation in elucidating both normal and abnormal structure and function of 
the brain of vertebrates, and moreover they possess an enormous potential for 
the production of new neurons in the adult brain. In aging research, several fish 
species exhibit gerontological characteristics and provide research opportunities 
for disease modeling, drug discovery, and regenerative medicine.  
This PhD thesis has developed a new teleost model organism N. furzeri, which is 
the shortest-lived vertebrate which can be cultured in captivity. This  teleost 
shows typical signs of aging and represents an ideal model to assess the role of 
different physiological and environmental parameters on aging and lifespan 
determination.  
The topic of this dissertation is the study of the organization of brain of N. 
furzeri and the neuroanatomical description of the occurrence of neurotrophins.  
The contruction of the brain atlas is a clear and fundamental guide to the 
structural and functional organization of the N. furzeri CNS, and provides 
informative reading for subsequent neurobiological surveys. The atlas has been 
the substratum for the neuroanatomical description of the occurrence of 
neurotrophins, both mRNA and protein, within the CNS. Neurotrophins are 
secreted proteins that link nervous system structure and function in vertebrates. 
They regulate neuronal survival, and regulate patterns of dendrites and axons, 
synaptic function, memory, learning, and cognition; abnormalities in 
neurotrophin function underlies neurological disorders. BDNF, NGF, NT-3, NT-
4 and NT-6, all members of neurotrophins family, have been identified on 
expressed sequence tag (EST)-to-genome and genome-to-genome comparisons 
of N. furzeri and other teleosts. ISH and IHC analysis of cells expressing 
mRNAs for the neurotrophins revealed a specific expression pattern for each of 
the mRNAs and proteins. The analysis of sites of neurotrophin synthesis was 
performed with ISH technique using two LNA/DNA and oligonucleotide probes, 
encoding mature N. furzeri neurotrophin protein. The parallel 
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immunohistochemical investigation, along with specific affinity-purified 
antibodies, was carried out to generate a detailed mapping of neurotrophin 
protein throughout the adult N. furzeri CNS. All neurotrophins occur in the brain 
of N. furzeri, except NT-3. The obtained results show a high level of correlation 
between ISH and IHC in the evaluation of neurotrophins in the brain of N. 
furzeri. The data, indeed, have revealed that several nuclei expressing 
neurotrophin mRNAs were correlated to the neurotrophin specific proteins 
throughout the CNS; the sites of mRNA synthesis and protein storage have 
suggested hypothesis on the mechanisms  of retrograde/anterograde transport. 
Moreover, the sites of synthesis have been often identified as active proliferative 
areas of fish brain, where new neurons are generate or regenerate. The latter 
observation might suggest a role of neurotrophins in the neurogenic and 
regeneration activities.  
This work provides new aspects of neurotrophic factors in the CNS of 
vertebrates, and it opens the opportunity to use N. furzeri as alternative model to 
investigate neurotrophin function and model related diseases. 
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